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Abstract 
MHC I Molecules in the Regulation of Neural Stem Cell Function and 
Cognition 
by 
Kai Lin Lin 
Proteins of the major histocompatibility complex class I (MHC I), previously 
known mainly for antigen presentation to cells of the immune system, have recently 
been shown to play a crucial role in both developmental neural refinement and adult 
synaptic plasticity. However, their function in non-neuronal cell populations in the brain 
or the impact of cellular changes regulated by MHC I molecules on behavioral outputs 
have yet to be investigated. In this dissertation, I identify novel, non-immune roles for 
two specific classical MHC I molecules (out of as many as 50 encoded in the murine 
genome) in the brain. I demonstrate that H2-Kb is a negative regulator of proliferation in 
neural stem cells (NSCs), a unique cell type amenable to regenerative biology. Using 
genetic mouse models as well as primary NSC cultures, I show that deletion or 
knockdown of H2-Kb molecules causes increased proliferation and neurogenesis in the 
adult hippocampus in vivo as well as in a cell-type specific environment in vitro. 
Transcriptome analysis of NSCs lacking H2-Kb reveals that this enhanced proliferative 
potential is due to an induction of several growth factor receptor signaling pathways. I 
found functionally that one mechanism by which H2-Kb may exert its inhibition is 
through a physical interaction with fibroblast growth receptor 1, putatively dampening its 
signaling. Though also highly expressed in the hippocampus, I show that the other 
classical MHC I molecule, H2-Db, does not play a major role in NSC function. I thus 
	 viii	
probed other hippocampal processes and revealed a developmental necessity H2-Db in 
preserving normal locomotion, anxiety-related behavior, and spatial and associative 
memory. Furthermore, I show that its acute ablation in the adult hippocampus can 
remarkably improve hippocampus-dependent memory. The hippocampus, an 
extraordinary brain structure in its capacity for immense plasticity throughout life, is 
particularly vulnerable to deleterious conditions such as disease and aging. As MHC I 
molecules are known to increase in the aged and injured brain, understanding their 
precise functions in the hippocampus may provide opportunities to seize its neuroplastic 
and regenerative potential for therapeutic intervention.  
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Chapter 1 
Introduction 
 
 
Major histocompatibility complex class I (MHC I) proteins are most well known for 
their role in antigen presentation and immunological surveillance in the adaptive 
immune system (Neefjes et al., 2011). Although MHC I molecules are expressed by all 
nucleated cells, a long-held central dogma in the field of neuroimmunology describes 
certain organs— such as the central nervous system (CNS)— as being immune-
privileged, with this ability to evade normal inflammatory responses being imparted by a 
near absence of classical immune molecules under healthy conditions (Joly et al., 1991; 
Murphy, 1923). In the last two decades however, this belief has been challenged 
following the discovery that immune components are not only present in the CNS, but 
also play critical roles in brain development and synaptic function (Boulanger, 2009; 
Shatz, 2009). However, their roles in non-neuronal cell types in the brain or how the 
cellular changes they regulate influence behavioral outputs have never been elucidated. 
This dissertation explores non-canonical roles for specific MHC I molecules in the 
context of previously unstudied cell types and functions of the brain: H2-Kb in the 
regulation of neural stem and progenitor cell function and hippocampal neurogenesis, 
and H2-Db and its modulation of hippocampus-dependent cognitive function.  
 
Structure and Classification of MHC I Molecules 
MHC molecules (referred to as human leukocyte antigen [HLA] complex in 
humans, and H-2 complex in mice) are a set of cell surface proteins critical in facilitating 
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the immune system’s ability to recognize and respond to foreign antigens in the body. 
The MHC gene family can be classified into two major subgroups based on structure, 
expression, and function: class I (MHC I) and class II (MHC II). MHC II molecules are 
normally expressed by specialized immune cells, such as macrophages, B cells, and 
dendritic cells; they function to present extracellularly derived antigens to CD4-positive 
T cells, mounting a humoral response. MHC I molecules, which this dissertation will 
focus on, are expressed on the surface of all nucleated cells and present intracellular 
peptides to CD8-positive, cytotoxic T cells.  
MHC I molecules are trimeric in structure (Figure 1A), consisting of a 
transmembrane heavy chain, a smaller β2-microglobulin (β2m) light chain, and the 
antigenic peptide being presented (Bjorkman and Parham, 1990). The heavy chain is a 
44kD glycoprotein with three extracellular domains (α1-3) and short cytoplasmic tail of 
~30 amino acids; the α1 and α2 domains are highly polymorphic and form the peptide-
binding groove, while the membrane-spanning α3 domain is relatively conserved and 
carries sequence similarity to the immunoglobulin superfamily. The α3 domain also 
interacts with the CD8 co-receptor on T-cells in its classical immune role (Figure 1B). 
β2m is the invariant, 12kD subunit that is non-covalently bound to the MHC I heavy 
chain, with the ability to be shed off the cell surface and detected in the circulation. MHC 
I molecules bind peptides that are 8-10 amino acids long and present them on the cell 
surface to surveilling immune cells. The proteasome degrades intracellular proteins into 
these short peptides, which are then translocated from the cytosol into the lumen of the 
endoplasmic reticulum by the transporter associated with antigen processing 1 (Tap1). 
Here, the α chain of MHC I molecules can bind the peptide and, after association of 
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β2m, the complete MHC I complex can be stably expressed on the cell surface 
(Williams et al., 2002).  
MHC I molecules can be further divided into two groups: classical MHC I 
molecules (HLA-A, HLA-B, and HLA-C in humans) which are the polymorphic, trimeric 
structures described above, as well as non-classical MHC I molecules. These non-
classical counterparts may be less polymorphic in the α1 and α2 domains, or may lack 
components such as the peptide, β2m, or the α3 domain. These molecules are less well 
studied but have been ascribed roles as antigen-presenting and antigen-independent 
ligands in the innate immune system (Allen and Hogan, 2013). This dissertation will 
focus on the two classical MHC I subtypes found in C57BL/6 mice, H2-Kb and H2-Db. 
  
Canonical Function of MHC I in the Immune System  
 MHC I molecules facilitate the ability of the immune system (in particular, T cells) 
to recognize self versus non-self antigens and to appropriately initiate either 
autotolerance or destruction of infected host cells. They display proteolytically digested 
peptides from intracellular proteins on the surface of all nucleated cells for sampling by 
cytotoxic T cells. Cytotoxic T cells express T cell receptors (TCR) that recognize 
epitopes presented by MHC I, as well as CD8 co-receptors, which confer binding 
specificity to the α3 domain of the MHC I complex (Figure 1B). When intracellular 
pathogens or cancerous transformation are detected, the TCR signaling pathway is 
initiated. Subsequent steps of cell-mediated immunity involve the release of cytolytic 
proteins by cytotoxic T cells, which trigger the caspase cascade in the infected cell and 
lead to its apoptosis (Broere et al., 2011).  
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 TCR binding is the canonical interaction exhibited by MHC I molecules, but MHC 
I molecules have a multitude of receptors in the immune system with which they are 
capable of interacting. These include receptors found on natural killer (NK) cells, such 
as paired immunoglobulin-like (Pir) and Ly49 receptors, which can have either activating 
or inhibitory functions in NK immune synapse formation (Long, 2008).  
 The roles of MHC I molecules in the immune system have been extensively 
characterized. In contrast, the expression and function of MHC I molecules outside the 
immune context, and perhaps independent of antigen presentation, are less well 
understood. Significant progress, however, has been made in defining their non-
canonical roles in other capacities— in particular the CNS— since their discovery in an 
unbiased screen for genes involved in synapse remodeling two decades ago. 
 
Immune Privilege Reconsidered: Roles of MHC I in the CNS 
During critical periods in brain development, early neuronal activity can sculpt the 
connections maintained in long-lasting circuits through the preservation and 
strengthening of certain synapses and the elimination of weaker ones. By using the 
developing visual system as a model, Corriveau et al. sought to screen for the gene 
expression changes that might translate this initial strengthening of synaptic strength 
into long-term structural changes in neurons (Corriveau et al., 1998). Surprisingly, it was 
found that genes affected by neural activity blockade in this system included MHC I, 
suggesting its involvement in synaptic development and maintenance. This finding was 
unexpected because until relatively recently, it was thought that neurons did not express 
MHC I or other classical immune components except during damage or viral infection 
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(Joly et al., 1991). Beginning with this study, there is now a growing body of literature 
demonstrating that not only are MHC I molecules present in the healthy CNS, but that 
their expression can be influenced by neural activity and that they play critical roles in 
nervous system development and synaptic plasticity.  
 
Expression of MHC I and its receptors in the CNS 
 MHC I mRNA and protein can be found in the CNS across many species 
including rodents, cats, marmosets, and humans (Corriveau et al., 1998; Ribic et al., 
2011; Zhang et al., 2015), and is controlled in its temporal and spatial distribution. 
Expression in neurons and glial cells have been observed in the visual and olfactory 
systems, hippocampus, cerebral cortex, cerebellum, spinal cord, and motor neurons 
(Ishii and Mombaerts, 2008; Lindå et al., 1998; Massa et al., 1993; McConnell et al., 
2009a; Ribic et al., 2011; VanGuilder Starkey et al., 2012). In neurons, MHC I is 
expressed both pre- and post-synaptically, with distribution being developmentally 
dynamic. Although present throughout life in the mammalian CNS, MHC I levels are 
highest during early post-natal development and during aging (in the hippocampus) 
(Needleman et al., 2010; VanGuilder Starkey et al., 2012). 
 MHC I expression is also influenced by the activity state of the neuron. When 
activity is decreased via intracranial infusion of tetrodotoxin, MHC I mRNA 
correspondingly decreases; consistently, increasing activity by infusing kainic acid 
increases MHC I mRNA in the hippocampus and cortex (Corriveau et al., 1998).  
 The discovery of MHC I molecules in the CNS invites the question of whether its 
known immune receptors are also present, and more interestingly, are their functions in 
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the CNS comparable or unrelated to their immune roles? Indeed, adapter proteins in the 
TCR complex are expressed in the brain: CD3ζ is found throughout the brain and CD3ε 
is expressed in the cerebellum (Baudouin et al., 2008; Nakamura et al., 2007). 
However, functional TCR receptors themselves do not appear to be present in the CNS. 
Along with the lack of T cells in the uncompromised CNS, this observation casts doubt 
that MHC I is signaling through the canonical antigen presentation pathway. NK cells 
receptors—PirB, Ly49—are also found in hippocampal neurons in vivo, and in cultured 
cortical neurons, respectively (Syken et al., 2006; Zohar et al., 2008). These receptors 
may have neuronal functions dependent as well as independent on MHC I binding. In 
general, the pattern of MHC I / MHC I-related receptor expression in the brain is 
correlated with regions that exhibit high plasticity. 
 
Activity- dependent visual system development 
 CNS plasticity refers to the ability of neurons to change the strength of their 
connections or remodel their organization in response to various stimuli. The first direct 
evidence of MHC I molecules regulating neuronal plasticity was demonstrated in the 
mouse developing visual system, which elegantly models both visual input-independent 
and input-dependent remodeling in the lateral geniculate nucleus (LGN) and the primary 
visual cortex (V1). The early stage of development involves retinal ganglion cells 
projecting from both eyes to the thalamic dorsal LGN and forming segregated eye-
specific layers; these form due to early spontaneous activity from the retinal cells. LGN 
neurons then send projections to the V1 where their activity organizes layer IV of the 
visual cortex into eye-specific patches called ocular dominance columns; visual activity 
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coming from both eyes is required for proper maturation of synapses in the V1. Mice 
deficient for cell-surface expression of MHC I (β2m-/-Tap1-/-) cannot form the tightly 
localized, eye-specific regions in the LGN (Huh et al., 2000). The ipsilateral projections 
are expanded and there is improper segregation between left and right eye territories, 
caused by extraneous, inappropriate synapses that are normally removed during 
development in WT mice. The inputs are able to make it into the LGN, however, 
suggesting that MHC I is involved only in regulating the later processes of finer synaptic 
refinement and pruning rather than early, gross patterning of the developing visual 
system.  
 A more specific mouse model, lacking just two of the over 50 MHC I genes 
(specifically H2-Kb and H2-Db double knockout, KD-/-), show similar aberrant eye-
specific segregation in the LGN. In addition, KD-/- mice also show enhanced ocular 
dominance plasticity compared to WT mice (Datwani et al., 2009). This experimental 
paradigm is done at the onset of the visual cortex critical period at P22 and tests the 
ability of the inputs of one eye to expand into binocular zones in the V1 when the other 
eye is surgically closed or removed. Datwani et al. showed that KD-/- mice had 
increased expansion of cortical inputs from the open eye as measured by in situ 
hybridization of the immediate early gene Arc, when compared to WT animals. 
 Together, these data directly implicate MHC I, specifically the two classical 
molecules H2-Kb and H2-Db, as mediators of synapse weakening and removal during 
retinogeniculate refinement and reveal their role in negatively regulating ocular 
dominance plasticity.   
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Neurite outgrowth and establishment of synapses 
 MHC I molecules have been shown to modulate the structure of individual 
neurons as well as the connections that form between neurons. They limit the growth of 
dendrites and axons in vitro: axonal extension of cultured retinal ganglion cells towards 
thalamic explants overexpressing H2-Db is stunted and addition of exogenous, 
recombinant MHC I molecules limits neurite outgrowth in retinal explants (Escande-
Beillard et al., 2010; Wu et al., 2011b).  Synaptogenesis is also affected by MHC I 
molecules in a similar bidirectional manner. Reduction of surface MHC I (via knockdown 
of β2m) increased the glutamatergic and GABAergic synapse density in cortical neurons 
in culture (Glynn et al., 2011). Conversely, overexpression of the H2-Kb isoform in 
cultured neurons elicited the opposite effect: a decrease in synaptic density. This was 
further corroborated in vivo in the visual cortex where it was observed that β2m-/- mice 
had higher synapse density compared to WT mice at P8, P11, P23 and P60. The 
inhibitory role that MHC I molecules play in the growth of neurites and establishment of 
synaptic connections are in line with the overgrowth phenotypes seen in MHC I 
knockouts during visual system development.  
 
Synaptic plasticity 
 In additional to structural modulation, MHC I molecules can also functionally 
regulate transmission of electrical signals between synapses as well as influence 
synaptic plasticity. In cultured hippocampal neurons and cortical slices from β2m-/-  
Tap1-/- mice, miniature excitatory postsynaptic current frequency (but not amplitude) is 
increased (Goddard et al., 2007), suggesting an enhancement of presynaptic release 
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properties. When presynaptic release is correlated with postsynaptic receptor activation 
for a prolonged time, a type of plasticity called long-term potentiation (LTP) – or an 
increase in synapse strength— occurs between participating neurons. LTP is widely 
considered one of the major cellular mechanisms facilitating learning and memory. 
When two neurons fire in an uncorrelated manner for a prolonged time, long-term 
depression (LTD) will occur and the weakened synapse is eventually eliminated. In the 
same β2m-/-Tap1-/- mice, hippocampal LTD is absent while LTP is enhanced (Huh et al., 
2000). MHC I molecules function to dampen synaptic strength and plasticity, in line with 
their inhibitory roles in neuronal structure. 
 
MHC I signaling in the brain 
 It is clear that MHC I molecules are critical mediators of CNS development, 
structure, and plasticity, but the underlying mechanisms are less well studied. As these 
molecules have a short cytoplasmic tail, it is generally assumed that MHC I acts by 
interaction with other receptors rather than its own intracellular signaling. In the brain, 
MHC I may engage in trans- synaptic interactions with immune-related molecules on 
neighboring neurons. Animals lacking CD3ζ phenocopy β2m-/-Tap1-/- and KD-/- mice, 
showing enhancements in retinogeniculate projection, increased retinal ganglion cell 
dendritic branching, and enhanced LTP with absent LTD (Huh et al., 2000; Xu et al., 
2010). Mice deficient of PirB have enhanced ocular dominance plasticity and cultured 
neurons treated with Ly49 anitbodies have inhibited neurite outgrowth but increased cell 
survival (Syken et al., 2006; Zohar et al., 2008); as these phenotypes are similar to 
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MHC I deficient mice, it suggests that MHC I and these immune receptors may be 
involved in the same pathway. 
  In addition to trans interactions, MHC I can also form complexes or bind to 
adjacent proteins in cis interactions (Figure 1B). Cis-interacting proteins comprise of 
immune receptors (such as NK receptors and various cluster of differentiation 
molecules) but also non-immune components like insulin receptors, insulin-like growth 
factor receptors, epidermal growth factor receptors (EGFR), luteinizing hormone 
receptors, amongst others (Arosa et al., 2007). When interacting on the same surface, 
MHC I has been implicated in regulating trafficking and internalization of growth factor 
and hormone receptors (Olsson et al., 1994; Schreiber et al., 1984; Solano et al., 1988). 
Examples of non-immune MHC I interactions in the CNS include the regulation of 
vomeronasal pheromone receptor trafficking by non-classical MHC I molecules, and the 
negative modulation of hippocampal synapse density by inhibition neuronal insulin 
receptors (Dixon-Salazar et al., 2014; Loconto et al., 2003). 
 A thorough examination of MHC I and MHC I-related receptor expression 
patterns, both across time and the various cell types in the brain, would provide 
important clues to how these immune molecules are influencing CNS functions and 
plasticity. Currently, the field has focused on MHC I in neurons but their expression and 
roles in non-neuronal CNS cell types have remained completely understudied. Neural 
stem or radial glial cells (NSCs), capable of generating functional neurons, divide 
embryonically to populate the CNS during development as well as postnatally to confer 
additional plasticity to the brain partially throughout life. Chapter 3 of this dissertation will 
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explore the role of classical MHC I molecules in regulating NSC function and 
hippocampal neurogenesis.  
 
Hippocampal Neurogenesis 
A brief history 
Neurogenesis, the process by which NSCs generate new neurons, is most active 
during embryonic development but was discovered to continue postnatally in a variety of 
species including rodents, birds, lizards, and humans (Altman and Das, 1965; Eriksson 
et al., 1998; Garcia-Verdugo et al., 1989; Goldman and Nottebohm, 1983; Gould et al., 
1999; Lois and Alvarez-Buylla, 1994). In rodents, the primary regions of neurogenesis 
are the ventricular-subventricular zone of the lateral ventricles (Altman, 1969; Lois and 
Alvarez-Buylla, 1993) and the subgranular zone in the dentate gyrus (DG) of the 
hippocampus (Altman and Das, 1965; Cameron et al., 1993), a structure critical to the 
formation of new memories. In the subgranular layer of the adult DG, Seri et al. were 
the first to describe cells expressing glial fibrillary acidic protein (GFAP) as the stem 
cells that give rise to intermediate progenitors, which then become neuroblasts (Seri et 
al., 2001). Immature neurons migrate into the inner granule cell layer where 
differentiation into DG granule cells occurs. In a process that spans about four weeks, 
new neurons are born that receive inputs from the molecular layer and send projections 
through the hilus and into the CA3 of the hippocampus.  The integration of adult-born 
neurons into existing hippocampal circuitry suggests their importance in learning and 
memory. A growing body of evidence, with analyses at the cellular, circuitry, and 
behavioral levels, have suggested significant contribution of adult hippocampal 
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neurogenesis to spatial learning and memory, pattern discrimination, trace conditioning 
and contextual fear conditioning, and even clearance of previous hippocampal traces 
(reviewed in Deng et al., 2010). However, evidence for specific functions of adult 
neurogenesis in these processes is still inconsistent between studies and requires 
further investigation (reviewed in Oomen et al., 2014). Dysregulation of neurogenesis is 
apparent in variety of neuropsychiatric disorders and aging, and often associated with a 
decline in cognitive capacity (Haughey et al., 2002; Kuhn et al., 1996; Parent et al., 
1997; Toro and Deakin, 2007; van Wijngaarden and Franklin, 2013). Functional ongoing 
neurogenesis offers the maturing brain a striking plasticity, and understanding its 
regulators can help harness this innate regenerative capacity of the CNS in the 
treatment of brain disorders.  
 
Mechanisms regulating adult neurogenesis in the murine brain 
Adult neurogenesis is a tightly regulated process, with influences stemming both 
intrinsically and from the external niche or systemic environment.  
• Intracellular 
Cell-cycle regulators, transcription factors, and epigenetic factors are three major 
classes of cell-intrinsic regulators of adult NSC functions. Cell cycle inhibitors such as 
p16 and p53 can maintain quiescence of adult NSCs, transcription factors like the 
FoxOs, Sox2 and TLX are important in the maintenance of precursor pools, and 
epigenetic factors like Tet2 and mixed-lineage leukemia 1 (Mll1) can influence NSC 
proliferation and differentiation (Ehm et al., 2010; Gontier et al., 2018; Lim et al., 2009; 
Paik et al., 2009; Qu et al., 2010). 
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• Extracellular/ Systemic 
Morphogens, such as Notch, Shh, Wnts, and BMPs, exert various influences on 
adult NSCs to fine-tune their behavior, with some regulating cell proliferation while 
others maintain the stem cell pool (Choe et al., 2016). Growth factors, 
neurotransmitters, and hormones in the local niche are also major players in the 
extracellular regulation of NSC function (Zhao et al., 2008). Epidermal growth factor 
(EGF) and fibroblast growth factor 2 (FGF2) are required for maintaining NSCs in vitro, 
and also promote proliferation in vivo (Kang and Hebert, 2015; Kuhn et al., 1997; Lee et 
al., 2009). In the dentate gyrus, NMDA-type glutamate receptor activity is inversely 
correlated with NSC proliferation and GABAergic influence can promote their 
differentiation (Cameron et al., 1995; Tozuka et al., 2005). 
Outside of the niche, systemic or environmental factors can also influence adult 
neurogenesis. Exercise, enriched living environment, learning, and exposure to young 
blood are able to increase generation of adult-born neurons, whereas chronic stress, 
inflammation, diabetes, and aging can impair adult neurogenesis (Kempermann et al., 
1997; Kuhn et al., 1996; Mirescu and Gould, 2006; van Praag et al., 1999; Stranahan et 
al., 2008; Villeda et al., 2011).  
 
Immune regulators of neurogenesis in the murine brain 
 There is also precedent that the process of adult neurogenesis is sensitive to 
immune influence, both from resident CNS macrophages called microglia as well as 
peripheral lymphocytes. Mice injected intrathecally or systemically with 
lipopolysaccharide (LPS), a potent activator of innate immunity, showed decreases in 
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hippocampal neurogenesis (Monje et al., 2003). This was attributed to a robust 
activation of microglia in the brain, leading them to adopt a cytotoxic phenotype and to 
secrete pro-inflammatory factors like TNF-α and IL-6. A multitude of cytokines such as 
interleukins, interferons, and tumor necrosis factor, secreted by both CNS and non-CNS 
cell-types in response to inflammation, are known to bidirectionally regulate various 
aspects of NSC function (reviewed in Borsini et al., 2015). Peripheral immune cells have 
also been shown to support adult neurogenesis under physiological conditions. 
Immune-deficient (both nude and severe combined immunodeficiency [SCID]) mice 
show impairments in hippocampal neurogenesis, which could be partially restored upon 
reconstitution of T cells; the secretion of brain-derived neurotrophic factor (BDNF), 
either directly by T cells or in directly by NeuN-positive neurons via stimulation by T cell-
derived cytokines, is thought to underlie this observation (Ziv et al., 2006). The 
modulation of immune components has, excitingly, been shown to mitigate the 
neurogenic decline that occurs in aging. β2m, the light chain of MHC I molecules, 
decreases hippocampal neurogenesis when exogenously added, but aged animals 
genetically lacking β2m (β2m-/-) display an increase in newborn neurons compared to 
their aged WT counterparts (Smith et al., 2015). Moreover, aged β2m-/- mice also show 
enhanced learning and memory in the radial arm water maze (RAWM) and contextual 
fear conditioning, tasks that are dependent on the hippocampus. Whether or not these 
cognitive improvements are a direct cause of improved neurogenesis is unclear, but 
there is strong support that immune modulation of neural plasticity and cognitive 
function can occur in various ways.  
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Recent findings in human adult neurogenesis 
 The pioneering study describing dividing cells in the adult human brain generated 
excitement, as the prospect of harnessing newborn neurons to promote human health 
became a potential possibility. In this study, postmortem brain tissue of adult patients 
who received infusions of the thymidine analog bromodeoxyuridine (BrdU) showed its 
incorporation into dividing cells in the hippocampus as previously seen in rodents 
(Eriksson et al., 1998). Subsequent studies used complementary approaches—
histological analysis of endogenous markers of immature neurons (Knoth et al., 2010) 
and radiocarbon dating (Spalding et al., 2013)— to demonstrate similar findings. 
Though exciting, the existence of adult neurogenesis has been contentiously debated in 
the past, with flawed methodology being cited (Rakic, 2002). The debate continues 
today as two prominently published studies demonstrate opposite findings: one report 
concluded that neurogenesis in the human hippocampal DG drops to undetectable 
levels during childhood (Sorrells et al., 2018), whereas the other reported lifelong 
hippocampal neurogenesis in humans (Boldrini et al., 2018). While many questions 
remain unanswered, these new papers challenge us to look forward, optimizing our 
research questions regarding plasticity and refining our techniques as they pertain to 
the human brain.  
 
Cognition  
 Cognition is an immensely wide-ranging process that involves the acquisition of 
knowledge, and the use of this knowledge to generate new knowledge. Learning and 
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memory mechanisms are integral to cognitive function, and thus a brief discussion of a 
structure intricately involved in the process, the hippocampus, is warranted.  
 
Anatomy and connectivity of the hippocampal formation 
 Physically, the hippocampus resides both downstream and upstream of cortical 
association regions of the CNS, making it a prime structure for the integration of multi-
modal sensory information (reviewed in Sweatt, 2010). Sensory information from the 
cortex funnels through the perirhinal and entorhinal cortices into the DG of the 
hippocampus, and glutamatergic dentate neurons then project through the Cornu 
Ammonis (CA) regions of the hippocampus, CA3 and CA1. Information leaves the 
hippocampus through CA1 neurons projecting to the ipsilateral and contralateral 
entorhinal cortices. The hippocampal formation is also reciprocally connected with the 
prefrontal cortex, a brain region implicated in planning complex cognitive behavior and 
decision-making.  
 Within the hippocampus, changes in the strength of connections between 
neurons is widely assumed to be the cellular mechanism by which memories are 
encoded (reviewed in Martin et al., 2000). Long-term potentiation (LTP) or long-term 
depression (LTD) are two specific processes thought to underlie selective strengthening 
or weakening of pertinent synapses (Bliss and Collingridge, 1993; Kessels and Malinow, 
2009). They occur when repetitive, coincident depolarization of a set of synapses 
causes activation of N-methyl-D-aspartate (NMDA)-type glutamate receptors, resulting 
in subsequent changes to the trafficking and function of α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA)-type glutamate receptors. A large magnitude, transient 
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activation of NMDA receptors leads to LTP via AMPA receptor insertion, whereas weak, 
persistent activation of NMDA receptors induces removal of AMPA receptors resulting in 
LTD. The result is a long-lasting modification of synaptic strength between two or more 
synapses involved in the circuit, a property thought to be necessary for learning and 
memory (Kessels and Malinow, 2009).   
 
Hippocampal-dependent cognitive functions 
 Although there is no unifying model of precisely how the hippocampus encodes a 
memory, it has been firmly established that the hippocampal formation is critical in 
facilitating long-term memory consolidation, spatial cognition, temporal information 
processing, and constructing multi-modal relationships between objects in the 
environment (reviewed in Sweatt, 2010). The types of studies that lend support to the 
hypothesis that the hippocampus regulates memory consolidation include lesioning 
studies, pharmacological infusions, in vivo recordings during behavioral testing, 
observation of molecular changes after learning, and a multitude of genetic engineering 
and optogenetic studies (Liu et al., 2012; reviewed in Martin and Morris, 2002). The 
connectivity of the hippocampus puts it in prime position to carry out functions which 
can be summarized as two main tasks: the processing of a wide variety of information 
from the environment, and the download of this information for storage as long-term 
memory.  
 
Immune modulation of learning, memory, and plasticity 
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 Memories, like the neural processes that encode them, are highly malleable. The 
number of players involved in the regulation of learning, memory, and hippocampal 
plasticity is immense; but as with hippocampal neurogenesis, these processes are 
susceptible to influence by immune molecules and cells despite their confinement to the 
immune-privileged CNS. Under quiescent, physiological conditions, immune 
components including T cells, inflammatory cytokines (primarily IL-1, IL6, and TNF-α), 
and prostaglandins can help facilitate learning and memory (reviewed in Yirmiya and 
Goshen, 2011). These immune-related molecules may exert influence on cognitive 
function by directly affecting the underlying processes of hippocampal LTP and LTD: 
blocking IL-1β receptors after the induction of LTP impairs its maintenance (Schneider 
et al., 1998), blocking TNF-α signaling reduces synaptic strength by decreasing AMPA 
receptor expression (Beattie et al., 2002), and inhibition of prostaglandin production by 
ibuprofen resulted in impaired hippocampal LTP (Shaw et al., 2003). However, in 
conditions of strong immune stimulation (e.g. injury, stroke, autoimmune disorders, 
pathogens, or aging), the normally pro-cognitive roles these immune molecules and 
cells play can quickly become detrimental. Indeed, there is ample evidence of the 
involvement of inflammatory mediators in acute CNS injury (such as brain trauma and 
epilepsy) and well as chronic neurological conditions (such as multiple sclerosis, 
Alzheimer’s disease, Parkinson’s disease, and aging itself) (Lucas et al., 2006; McGeer 
and McGeer, 2004), many of which present with cognitive decline. 
  
 The hippocampus is a remarkable brain structure in its capacity for immense 
plasticity throughout life, both at the synaptic level as well as in its ability to generate 
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new neurons. This degree of neuroplasticity might also confer it a marked vulnerability 
to deleterious conditions such as disease and aging (Bartsch and Wulff, 2015). Given 
the intricate involvement of inflammatory processes and immune components under 
these circumstances, understanding how specific molecules shape and misshape our 
brains in development and disease is of utmost importance. With further knowledge of 
its modulators, the unique level of neuroplasticity and regenerative potential of the 
hippocampus provides hope for future therapeutic interventions.  
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Figure 1. Structure and interactions of MHC I molecules. MHC I molecules are 
trimeric in structure, consisting of a heavy chain, light chain, and the peptide fragment 
being displayed. The heavy chain consists of three extracellular domains (α1-3) and 
short cytoplasmic tail of ~30 amino acids; the α1 and α2 domains are highly 
polymorphic and form the peptide-binding groove, while the membrane-spanning α3 
domain is relatively conserved and carries sequence similarity to the immunoglobulin 
superfamily. β2m is a subunit, which is non-covalently bound to the MHC I heavy chain 
(A). MHC I molecules can interact in trans with T cell receptors (TCR) on CD8+ T cells 
which sample the peptide, as well as CD8 co-receptors, which confer binding specificity 
to the α3 domain of the MHC I complex. MHC I molecules can also interact in cis with 
other putative binding partners and receptors (in green) on the same cell surface (B).  
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Chapter 2 
Materials and Methods 
 
Mouse Models 
All animal handling and use was in accordance with institutional guidelines 
approved by the University of California San Francisco IACUC. All mice were group-
housed under specific pathogen-free conditions under a 12 h light-dark cycle with ad 
libitum access to food and water. Mouse strains used are described in Table 1.  All 
studies in adult mice were conducted using male animals, and neural stem cells 
isolation was from male and female postnatal day 1 (P1) pups. The numbers of mice 
used to result in statistically significant differences was calculated using standard power 
calculations with α = 0.05 and a power of 0.8. We used an online tool 
(http://www.stat.uiowa.edu/~rlenth/Power/index.html) to calculate power and samples 
size based on experience with the respective tests, variability of the assays and inter-
individual differences within groups.  
 
Table 1. Mouse strain and relevant information 
Strain  Vendor Description References 
C57BL/6 Taconic Inbred wildtype from Taconic  
KD-/- 
(H2-Kb H2-Db 
double knockout) 
Taconic 
Double knockout mouse: K-/- and D-/- mice 
were intercrossed 
Perarnau et al., 
1999 
K-/- 
(H2-Kb knockout) Taconic 
Knockout mouse with 2nd and 3rd exons of 
the H2-Kb gene replaced with HPRT 
minigene 
Perarnau et al., 
1999 
D-/- 
(H2-Db knockout) Taconic 
Knockout mouse with loss of first three 
exons of the H2-Db gene  
Pascolo et al., 
1997 
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Generation of H2-Db conditional knockout mice for cell-type specific studies  
The strategy to generate a conditional knockout model in the mouse H2-D1 locus 
involved using a CRISPR/Cas-9 system to insert LoxM2 sequences in the 5’UTR or 
3’UTR regions, referred to as 5’ insertion site or 3’ insertion site, respectively. To 
achieve this model, three major steps were carried out. First, a mixture containing in 
vitro transcribed active guide RNA molecules (sgRNA) of 5’gRNA and its single-
stranded oligo deoxylnucleotide (ssODN) donor and Cas-9 protein was injected into 
C57BL/6 embryos. The 5’ LoxM2+ mice born from this injection were used for a second 
injection to target the 3’ site for LoxM2 insertion. Mice generated from both injections 
were subjected to PCR and sequencing for potential founders. Third, the potential 
founder was bred with WT mice to test germline transmission and to produce F1 mice. 
C57BL/6 embryos were then injected through cytoplasmic route with a CRISPR 
targeting cocktail containing 5’g26 with corresponding ssODN donor. Embryos well 
developed in vitro and were transferred into CD1 female mice. Twenty-six mice were 
born and 19 showed 5’ LoxM2 insertion. The female mice were mated with WT C57BL/6 
males for targeting the 3’ site. A total of 77 oocytes were injected with 3’g3 and 
corresponding ssODN. Sixty-eight were transferred into three surrogates. Four mice 
were born, two of which have both LoxM2 insertions, and are therefore potential 
founders. Both founders were mated with WT mice. The male founder produced two 
litters of seven F1 mice, with four being positive for floxed H2-D1 sites. In future 
experiments beyond this thesis, these mice will be crossed with various Cre mouse 
lines to test the effects of H2-Db knockout in specific cell types.  
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Immunohistochemistry  
Tissue processing and immunohistochemistry was performed on free-floating 
sections following standard published techniques (Bachman, 2013). Briefly, mice were 
anesthetized with a ketamine (100 mg/kg)-xylazine (10mg/kg) cocktail (Patterson 
Veterinary, Henry Schein) and transcardially perfused with cold PBS. Brains were 
removed, fixed in phosphate-buffered 4% paraformaldehyde, pH 7.4, at 4°C for 48 h 
followed by cryoprotection in 30% sucrose, and coronally sectioned at 40 µm with a 
cryomicrotome (Leica SM2010 R). Sections were washed three times in tris-buffered 
saline with 0.1% Tween 20 (TBST) and incubated in 3% normal donkey serum (Thermo 
Fisher Scientific) for 1 h. After overnight incubation in primary antibody (see Table 2 for 
details) at 4°C, staining was revealed using fluorescence conjugated secondary Alexa 
antibodies (1:500). Antigen retrieval for BrdU labeling required incubation in 3M HCl at 
37°C for 30 min before incubation with primary antibody; Nestin labeling required 
incubation in Citrate Buffer  (Sigma-Aldrich) at 95°C (3 times 5 minutes) prior to 
incubation with primary antibody. To estimate the total number of immunopositive cells 
per DG, confocal stacks of coronal sections of the DG (4-6 sections per mouse, 40 µm 
thick, 240 µm apart) were acquired on a Zeiss LSM 800. Immunopositive cells in the 
granule and subgranular cell layers were then counted and multiplied by 12 to estimate 
the total number in the entire DG.  
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Table 2. Primary antibodies 
Antigen Host Dilution Source 
BrdU Rat [BU1/75(ICR1)] 1:1000 Thermo Fisher 
CD68 Rat (FA-11) 1:250 Bio-Rad 
Cleaved Caspase 3 Rabbit, polyclonal 1:300 Cell Signaling 
Doublecortin Goat, polyclonal 1:500 Santa Cruz 
EGFR Mouse (A-10) 1:500 Santa Cruz 
Erk1/2 Rabbit (137F5) 1:1000 Cell Signaling 
FGFR1 Rabbit, polyclonal 1:400 Abcam 
FGFR3 Rabbit, polyclonal 1:500 Abcam 
GAPDH Mouse (6C5) 1:10000 Abcam 
GFAP Rabbit, polyclonal 1:1000 Dako 
H2-Kb Guinea pig, polyclonal 1:500 Covance (custom) 
Iba1 Rabbit, polyclonal 1:1000 Wako 
Map2 Mouse (HM-2) 1:1000 Sigma-Aldrich 
NeuN Mouse (A60) 1:1000 Millipore 
Nestin Mouse (rat-401) 1:200 Millipore 
Phospho Akt 
(Tyr450) Rabbit, polyclonal 1:1000 Millipore 
Phospho Erk1/2 
(Thr202/Tyr204) Rabbit (D13.14.4E) 1:2000 Cell Signaling 
Phospho S6 
(Ser235/236) 
Rabbit, polyclonal 1:1000 Cell Signaling 
Turbo-GFP Rabbit, polyclonal 1:10000 Thermo Fisher 
 
 
Western Blot Analysis 
Mouse hippocampi (isolated after transcardial perfusion with cold PBS) or 
primary neural stem cells (NSCs) were lysed in RIPA lysis buffer (500 mM Tris, pH 7.4, 
150 mM NaCl, 0.5% Na deoxycholate, 1% NP40, 0.1% SDS, and complete protease 
inhibitors; Roche). Protein lysates were mixed with 4x NuPage LDS loading buffer 
(Invitrogen) and loaded on a 4-12% SDS polyacrylamide gradient gel (Invitrogen) and 
subsequently transferred onto a nitrocellulose membrane. The blots were blocked in 5% 
milk in Tris-Buffered Saline with Tween (TBST) and incubated with primary antibody at 
4°C for 16h. Horseradish peroxidase-conjugated secondary antibodies and an ECL kit 
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(GE Healthcare/Amersham Pharmacia Biotech) were used to detect protein signals. 
Exposures were taken using a ChemiDoc imaging system (Bio-Rad) and quantified 
using ImageJ software (Version 1.8.0_91). GAPDH bands were used for normalization. 
 
RNA Isolation and qRT-PCR 
mRNA of NSCs was isolated by lysis with TRIzol Reagent (Thermo Fisher 
Scientific), separation with chloroform (0.2 mL per mL TRIzol), and precipitated with 
isopropyl alcohol. mRNA from DG tissue was isolated with the RNeasy Mini Kit 
(Quiagen). High Capacity cDNA Reverse Transcription Kit (Life Technologies) was used 
for reverse transcription of mRNA into cDNA and qRT-PCR was carried out using 
Power SYBR Green PCR Master Mix (Life Technologies) in a CFX384 Real Time 
System (Bio-Rad). Primers were: H2-Kb forward 5’-CGGCGCTGATCACCAAACA-3’, H2-Kb 
reverse 5’-AGCGTCGCGTTCCCGTT-3’; H2-Db forward 5’ -GTAAAGCGTGAAGACAGCTGC- 
3’, H2-Db reverse 5’-CTGAACCCAAGCTCACAGG-3’; GAPDH forward 5’-
GCATCCTGCACCACCAACTG-3’, GAPDH reverse 5’-ACGCCACAGCTTTCCAGAGG-3’.  
 
BrdU Administration and Quantification 
For short-term proliferation studies, mice were intraperitoneally injected with 
BrdU (50mg/kg body weight, Sigma-Aldrich) for 6 days (once per day) before sacrifice. 
For study of newborn neuron survival, mice were injected with BrdU (50mg/kg) for six 
days (once per day) and animals were sacrificed 28 days after administration. To 
estimate the total number of BrdU-positive cells in the DG, we performed fluorescence 
staining for BrdU on 4-6 hemibrain sections per mouse (40 µm thick, 240 µm apart). 
The number of BrdU-positive cells in the granule cell and subgranular cell layer of the 
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DG were counted and multiplied by 12 to estimate the total number of BrdU-positive 
cells in the entire DG. To quantify neuronal fate and maturation of dividing cells after 28 
day survival, BrdU-positive cells across 4-6 sections per mouse were analyzed by 
confocal microscopy for co-expression with NeuN.  
 
Stereotaxic injections 
Animals were placed in a stereotaxic frame and anesthetized with 2% isoflurane 
(Patterson Veterinary) (2 L per min oxygen flow rate) delivered through an anesthesia 
nose cone. Fur around the incision area was trimmed and ophthalmic eye ointment was 
applied to the cornea to prevent desiccation during surgery. Viral suspensions were 
injected bilaterally into the dorsal hippocampi using the following coordinates: (from 
bregma) anterior = −2 mm, lateral = 1.5 mm and (from skull surface) height = −2.1 mm. 
A 2 µL volume was injected stereotaxically over 10 min (injection speed: 0.20 µL per 
min) using a 5-µL 26s-gauge Hamilton syringe. To limit reflux along the injection track, 
the needle was maintained in situ for 8 min, slowly pulled out half-way and kept in 
position for an additional 2 min. The skin was closed using silk suture. Each mouse was 
injected subcutaneously with enrofloxacin (Bayer) antibiotic and buprenorphine (Butler 
Schein) as directed for pain, single-housed, and monitored during recovery.  
 
Isolation of Primary Neural Stem and Progenitor Cells from the Postnatal Mouse 
Hippocampus 
Primary neural stem and progenitor cell (NSPC) isolation and culture were 
preformed following previously published techniques (Babu et al., 2011). Hippocampi 
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were dissected from postnatal day 1 (P1) C57/BL6, KD-/-, K-/-, or D-/- mice and pooled by 
genotype for NSPC isolation without distinguishing genders. After removing superficial 
blood vessels, hippocampi were mechanically dissociated by fine mincing and 
enzymatically digested for 30 minutes at 37ºC in DMEM media containing 2.5U/ml 
Papain (Worthington Biochemicals), 1U/ml Dispase II (Boeringher Mannheim), and 
250U/ml DNase I (Worthington Biochemicals). NSPCs were purified using a 65% 
Percoll gradient and cultured (Neural Basal A medium supplemented with 2% B27 
without Vitamin A, 1% Glutamax, 1% Penicillin Streptomycin, 10ng/ml EGF, 10ng/ml 
bFGF) as a monolayer on poly-D-lysine and laminin-coated plates at a density of 105 
cells/cm2.  
 
NSPC Proliferation Assay 
WT or knockout NSPCs were seeded in 500 µL growth medium (Neural Basal A 
medium supplemented with 2% B27 without Vitamin A, 1% Glutamax, 1% Penicillin 
Streptomycin, 10ng/ml EGF, 10ng/ml bFGF) at a density of 10,000 cells/well on 
PDL/laminin-coated glass coverslips in a 24-well tissue culture plate. 24 h later, cells 
were treated with 20 µM BrdU or EdU for 6 h prior to fixing with 4% PFA. Acute 
knockdown of H2-Kb, H2-Db, or both, was induced by treating plated wildtype NSPCs 
with shRNA -encoding lentiviruses (6.5 × 106 to 7.5 × 106 viral particles per mL media) 
for three days prior to BrdU or EdU treatment as described. Cells were washed 3 times 
with PBS after fixation, blocked in 3% donkey serum, and incubated in primary antibody 
at 4ºC for 16 h. After 3 washes with PBS, BrdU staining was revealed with fluorescence-
conjugated secondary Alexa antibodies. EdU incorporation was revealed using a Click-
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iT EdU Alexa Fluor Imaging Kit (Thermo Fisher Scientific) and nuclei were 
counterstained with Hoechst 33342 (1:10000; Thermo Fisher Scientific). BrdU- or EdU-
positive cells were counted per field of view at three randomly determined locations per 
coverslip. In vitro experiments were conducted in triplicates for each condition, and 
repeated to ensure reproducibility. For inhibitor experiments, NSPCs were pre-treated 
for one hour with inhibitors (PD 161570, 0.1uM; AG 99, 10uM) prior to the 6 h EdU 
pulse and immunocytochemistry as described.  
  
NSPC Differentiation Assay 
WT or knockout NSPCs were seeded in 500 µL growth medium at a density of 
10,000 cells/well on PDL/laminin-coated glass coverslips in a 24-well tissue culture 
plate. 24 h later, media was removed and replaced with growth factor-free basal media 
(Neural Basal A medium supplemented with 2% B27 without Vitamin A, 1% Glutamax, 
1% Penicillin Streptomycin) to induce differentiation. Half the media was replaced every 
two days with fresh basal media, and cells were fixed after six days of differentiation in 
4% PFA. Immunocytochemistry was conducted as described above and Map2- or 
GFAP-positive cells were counted per field of view at three randomly determined 
locations per coverslip. In vitro experiments were conducted in triplicates for each 
condition, and repeated to ensure reproducibility. 
 
Cell Cycle Analysis by Cumulative EdU Labeling 
WT and K-/- NSPCs cultured in vitro in growth media were treated with 20 µM 
EdU at 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, or 24 h prior to fixation. Cells that 
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incorporated EdU were labeled using the Click-iT Plus EdU Alexa Fluor Flow Cytometry 
Kit, and percentage of EdU+ cells was determined by flow cytometry. The labeling index 
(LI; percent of total cells positive for EdU) was plotted over time, increasing linearly until 
a plateau (which corresponds with the growth fraction [GF], or maximum percentage of 
cells actively proliferating) was reached. The data can be fitted with two regression lines 
(as described in Nowakowski et al. 1989): one line which describes the initial linear 
increase, and another which describes the horizontal line corresponding to the GF. The 
time (in the x axis) where the two regression lines intersect is equal to Tc - Ts, where Tc 
is the cell cycle length and Ts is the S phase length. The intersect of the first regression 
line and the y axis is defined as the initial labeling index (Li0) and is equal to GF x 
Ts/Tc. Using these equations and the regression lines, Tc and Ts were calculated for 
WT and K-/- NSPCs. Each time point for both genotypes was conducted in duplicates.  
 
Growth Factor Receptor Signaling Pathway Analysis 
 WT and K-/- NSPCs were plated at 500 000 cells/ well in a 6-well dish in 
proliferation media for 24 hours. Cells were then subjected to absent (0 ng/mL), low (5 
ng/mL), or regular (20 ng/mL) EGF and FGF concentration conditions for one hour 
before protein was harvested as described above. Western blot analysis for growth 
factor receptor signaling pathway components (Erk1/2, Akt, ribosomal protein S6; see 
Table 1) was conducted for each condition. 
 
Viral Plasmids and Viruses 
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We generated lentiviruses (LVs) encoding shRNAs targeting endogenous H2-Kb 
(sh-K), H2-Db (sh-D), or both (sh-KD) using a lentiviral shRNA expression system 
(pGreenPuro shRNA, System Biosciences) according to the manufacturer's instructions. 
The targeted sequences were cloned into the pGreenPuro vector (H2-Kb, 5′-
GAATGTAACCTTGATTGTTAT-3′; H2-Db, 5’-ACCACACTCGATGCGGTATTTC-3’; H2-Kb H2-
Db, 5’-ACCCTCAGTTCTCTTTAGTCAA-3’). Plasmids were sequenced and shRNA-
mediated knockdown was tested via transfection of a neuro2a cell line and subsequent 
Western blot analysis for H2-Kb and qPCR analysis for H2-Kb and H2-Db.  
LV vectors were generated at the UCSF Viracore, with viral titers between 1.2 × 
109 to 1.5 × 109 viral particles per mL. LVs were stereotaxically injected into one 
hippocampus, and a control virus with a scrambled shRNA sequence (sh-control, 5’-
GGACGAACCTGCTGAGATAT-3’), based on the same viral plasmid, was injected as 
an internal control at the same location into the contralateral hemisphere. 
 
Co-Immunoprecipitation 
An N2a neuronal cell line (American Type Culture Collection, CCL-131), cultured 
in DMEM + 10% FBS, was used for co-immunprecipitation experiments. Cells were 
plated at a confluency of 85–90% and Lipofectamine 2000 (Invitrogen) was used as the 
transfection reagent. N2a cells were transfected with 3x FLAG-tagged H2-Kb and 
EGFR, FGFR1, or FGFR3. Protein overexpression was assessed with by Western blot 
analysis. Cells were lysed (20mM Tris, 150mM NaCl, 1mM EDTA, 1mM EGTA, 1% 
Triton X, 2.5mM sodium pyrophosphate decahydrate, 0.5% NP40, 1mM β-
glycerophosphate, 10mM NaF, 1ug/mL leupeptin) 48 h after transfection, and protein 
lysates (1mg) were incubated with Anti-FLAG M2 magnetic beads (Sigma-Aldrich) for 4 
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hours at 4°C. Beads were collected on a magnetic column, washed 3 times in cold TBS, 
and eluted directly in Laemmli buffer (Bio-Rad) at 95°C for 3 minutes.  
 
 
Bioinformatic analysis of single cell RNA-seq data from Shin et al., 2015 
Pseudo time assignment and read counts (CPM) for all cells were obtained from 
Shin et al. 2015. Read counts were log2 transformed (log2(CPM+1)) and scaled 
between 0 and 1 by dividing the normalized read count for each gene in each cell by the 
maximum expression value across all cells for the respective gene. Cells were then 
ordered according to their pseudo time estimate from early to late. Subsequently, a local 
polynomial regression line was fit alone the trajectory and the 95% confidence interval 
was calculated using the ggplot2 R package. Time points T1 and T2 were determined 
by the time of increasing Tbr2 expression (last stationary point of the Tbr2 regression 
line calculated in R). G1 and G2 cell cycle score were calculated as the summed 
expression of G1 and G2 markers, as published in Tirosh et al. 2016, divided by the 
median score across cells. 
 
RNA-Seq Library Construction 
After RNA isolation, RNA-Seq libraries were constructed using the Smart-Seq2 
protocol from Trombetta et al. 2014, with modifications. Briefly, 1 ng high quality RNA 
was reverse transcribed using SuperScript II (Life Technologies, 18064-014) with a 
poly-dT anchored oligonucleotide primer, and a template switching oligonucleotide 
primer that generated homotypic PCR primer binding sites. The cDNA underwent 10 
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rounds of PCR amplification using KAPA HiFi Hotstart (Kapa Biosystems, KK2601), 
followed by Ampure bead (Agencourt) cleanup. The quality of the amplified cDNA was 
tested using qPCR for GAPDH and nucleic acid quantitation. 1ng of high quality 
amplified cDNA was fragmented with the Tn5 transposase from the Illumina Nextera kit 
(FC-131-1096) to a median size of ~500bp. The fragmented library was amplified with 
indexed Nextera adapters (FC-131-1002) using 12 rounds of PCR. Final libraries were 
purified with Ampure beads, and quantified using a qPCR Library Quantification Kit 
(Kapa Biosystems, KK4824). Libraries were pooled for sequencing on an Illumina HiSeq 
2500.  
 
Bioinformatic Analysis of RNA-seq Data 
Quality trimming and adapter removal of raw FASTQ files was carried out with 
cutadapt (Martin, 2011). Only reads longer than 20 base pairs were kept for 
downstream analysis.  Subsequently, trimmed reads were mapped to the mouse 
genome (Grchm38) using HISAT2 (Kim et al., 2015). Transcripts given by the 
GENCODEv25 reference (http://www.gencodegenes.org/releases/current.html) were 
quantified with featureCounts (Liao et al., 2014), considering only uniquely aligned 
reads. Differential expression tests were calculated using DEseq2 (Love et al., 2014) 
and transcripts with an adjusted p-val < 0.05 were considered differentially expressed. 
ConsensusPathDB (Herwig et al., 2016) was used for calculation of pathway 
enrichments.  
 
Home Cage Nesting Behavior 
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 This test is a modified version of a previously published protocol (Deacon, 2012). 
Mice were individually housed and each cage was provided with a fresh nestlet, a 5cm 
square piece of pressed cotton. The nests were scored on a four-point scale (0-4) 
based on the following criteria: 0- the nestlet is largely untouched (>90% intact); 1- the 
nestlet is partially torn up (50-90% intact); 2- the nestlet is mostly shredded but there is 
no identifiable nest site; 3- a clearly identifiable, cratered nest, with walls higher than 
mouse body height on 50% of its circumference. Refer to Chapter 4, Figure 1 for 
representative photos. Mice were scored for nesting after 2, 6, and 12 hours after 
single-housing.  
 
Open Field Test 
Mice were placed in the center of an open 40 cm x 40 cm square chamber 
(Kinder Scientific) with no cues or stimuli and allowed to move freely for 10 min. Infrared 
photobeam breaks were recorded and movement metrics analyzed by the MotorMonitor 
software (Kinder Scientific).  
 
Elevated Zero Maze 
Mice were placed on elevated zero apparatus (53.98 cm diameter; 88.27 cm 
height; 5.08 cm wide racetrack; Kinder Scientific), which has two open sections and two 
walled sections forming a circle. Animals were placed at the junction of an open and 
closed arm and allowed to move freely for 10 min. Infrared photobeam breaks were 
recorded and movement metrics analyzed by the MotorMonitor software (Kinder 
Scientific). 
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Radial Arm Water Maze 
Our paradigm followed a previously described protocol (Alamed et al., 2006). The 
goal arm location containing a platform remained constant throughout the training and 
testing phases, and the start arm was changed during each trial. On day 1 during the 
training phase, mice were trained for 15 trials, with trials alternating between a visible 
and a hidden platform. On day 2 during the testing phase, mice were tested for 15 trials 
with a hidden platform. Entry into an incorrect arm was scored as an error, and errors 
were averaged over the training blocks (three consecutive trials). 
 
Contextual and Cued Fear Conditioning 
Our paradigm followed previously published techniques (Raber et al., 2011). 
Mice learned to associate the environmental context (fear-conditioning chamber) with 
an aversive stimulus (mild foot shock; unconditioned stimulus, US), which enabled 
testing for hippocampal-dependent contextual fear conditioning. The mild foot shock 
was paired with a light and tone cue (conditioned stimulus, CS) in order to also assess 
amygdala-dependent cued fear conditioning. Conditioned fear was displayed as 
freezing behavior. Specific training parameters were as follows: tone duration, 30 s; 
level, 70 dB, 2 kHz; shock duration, 2 s; intensity, 0.6 mA. On day 1, each mouse was 
placed in a fear-conditioning chamber and allowed to explore for 2 min before delivery 
of a 30-s tone (70 dB) ending with a 2-s foot shock (0.6 mA). Two minutes later, a 
second CS-US pair was delivered. On day 2, each mouse was first placed in the fear-
conditioning chamber containing the same exact context but with no administration of a 
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CS or foot shock. Freezing was analyzed for 2 min. One hour later, the mice were 
placed in a new context containing a different odor, cleaning solution, floor texture, 
chamber walls and shape. Animals were allowed to explore for 2 min before being re-
exposed to the CS. Freezing was analyzed for 30 sec after termination of the CS. 
Freezing was measured using a FreezeScan video tracking system and software 
(Cleversys, Inc). 
 
Data and statistical analysis 
Graphed data are expressed as mean ± SEM. Statistical analysis was performed 
with Prism 5.0 software (GraphPad Software). Means between two groups were 
compared with two-tailed, paired or unpaired Student’s t-test. Comparisons of means 
from multiple groups with each other or against one control group were analyzed with 2-
way ANOVA and Bonferroni or Fisher’s LSD post hoc tests. All histology and behavior 
experiments conducted were done in a randomized and blinded fashion. For each 
experiment, the overall size of the experimental groups corresponded to distinct 
animals. Unique samples were not measured repeatedly within the same 
characterization of a given cohort. 
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Chapter 3 
Role of Classical MHC I Molecules in Regulating Neural Stem 
and Progenitor Cell Function 
 
Proteins of the major histocompatibility complex class I (MHC I), previously 
known mainly for antigen presentation in the immune system, have recently been 
shown to be necessary for both developmental neural refinement and adult synaptic 
plasticity. However, their roles in non-neuronal cell populations in the brain have yet to 
be investigated. This study identifies classical MHC I molecule H2-Kb as a negative 
regulator of proliferation in neural stem and progenitor cells (NSPCs), cell types 
conferring inherent plasticity to the rodent brain. Adult animals with a genetic deletion 
(K-/-) or acute knockdown of H2-Kb in the dentate gyrus exhibit enhanced cell division 
and an increased number of adult-born neurons in the hippocampus. This proliferative 
phenotype is also observed in cultured K-/- progenitor cells devoid of influences from the 
neurogenic niche or systemic environment. Subsequent transcriptomic analysis of K-/- 
and wild type progenitors further revealed that endogenous H2-Kb molecules inhibit cell 
proliferation by dampening growth factor receptor signaling pathways, through a 
physical interaction with fibroblast growth factor receptor 1. These findings identify H2-
Kb as a novel regulator of cell proliferation through the modulation of growth factor 
signaling.  
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Introduction 
 Major histocompatibility class I (MHC I) proteins are most well known for their 
role in antigen presentation and immunological surveillance in the adaptive immune 
system (Neefjes et al., 2011). Although MHC I molecules are expressed by all nucleated 
cells, long-held dogma in the field of neuroimmunology described the central nervous 
system (CNS) as being immune-privileged, with the ability to evade normal 
inflammatory responses imparted by a near absence of classical immune molecules 
under physiological conditions (Joly et al., 1991; Murphy, 1923). In the last two decades 
however, this belief has been challenged following the discovery that immune 
components, such as complement, cytokines, and MHC I molecules, are not only 
present in the CNS but play many critical roles in brain development and function 
(Deverman and Patterson, 2009; Garay and McAllister, 2010; Shatz, 2009; Stevens et 
al., 2007). More specifically, the classical MHC I molecules, H2-Kb and H2-Db, have 
been demonstrated in the CNS to negatively regulate visual system plasticity, neurite 
outgrowth, synapse density, and synaptic strength (Huh, 2000; Datwani et al., 2009; Wu 
et al., 2011; Dixon-Salazar et al., 2014) Notwithstanding, their roles in regulating cellular 
functions beyond mature neuronal cells types have yet to be explored. 
Neural stem cells (NSCs), capable of producing functional neurons during 
embryonic and perinatal development as well as partially throughout life, represent a 
unique cell type critical in the formation of the CNS and potentially amenable to 
regenerative biology. NSCs of the dentate gyrus (DG) reside in a specialized niche that 
supports their maintenance, proliferation, and differentiation into excitatory granule cells 
that integrate into hippocampal circuitry and confer plasticity (Christian et al., 2014). 
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This fine-tuned process is responsive to modulation by cell-intrinsic mechanisms, 
including transcription factors such as Sox2, TLX, and FoxOs and epigenetic factors like 
Tet2, as well as changes to the neurogenic niche and systemic environment through 
manipulations such as exercise and exposure to young blood (Favaro et al., 2009; 
Gontier et al., 2018; Paik et al., 2009; van Praag et al., 1999; Qu et al., 2010; Villeda et 
al., 2014). Importantly, neurogenesis can be regulated by immune system components 
such as cytokines, toll-like receptors, and T cells (Borsini et al., 2015; Rolls et al., 2007; 
Ziv et al., 2006). One such factor, β2-microglobulin, which is the non-covalently bound 
light chain of MHC I, has been implicated as a systemic factor inhibiting neurogenesis 
(Smith et al., 2015). However, the role of MHC I molecules themselves in regulating 
neural stem and progenitor cell (NSPC) function have never been studied. Given the 
roles of MHC I molecules in suppressing neural processes and the susceptibility of 
NSPCs to immune influence, I sought to investigate the roles of H2-Kb and H2-Db in 
NSPC function. 
Using a combination of in vivo genetic mouse models and in vitro NSPC 
functional assays, I specifically identify H2-Kb as a unique negative regulator of NSPC 
proliferation and adult hippocampal neurogenesis. Additionally, I used transcriptomic 
and biochemical analysis to provide evidence that loss of H2-Kb in NSPCs enhances 
proliferation through fibroblast growth factor receptor 1 signaling pathways. Together, 
these data demonstrate a novel, non-canonical role for a specific MHC I molecule, H2-
Kb, in NSPCs. As psychiatric disorders, neurodegenerative diseases, stroke, and aging 
can impact the process of neurogenesis (Kaneko and Sawamoto, 2009; Kuhn et al., 
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1996), a better understanding of specific molecules regulating NSPC function may allow 
us to harness the innate regenerative capacity of the CNS to combat these brain insults.  
 
Results 
Absence of H2-Kb and H2-Db increases neurogenesis in the adult hippocampus 
I first sought to investigate the role of H2-Kb and H2-Db in negatively regulating 
adult neurogenesis in the hippocampal dentate gyrus (DG) in vivo. Taking advantage 
that H2-K1 (encoding H2-Kb) and H2-D1 (encoding H2-Db) genes are both on 
chromosome 17 of the mouse genome, I made use of a genetic knockout mouse model 
in which excision of both genes co-segregate on the same chromosome in a single 
mutant mouse (KD–/–). Neurogenesis was assessed in the hippocampus of adult (3 
months) KD-/- mice and age-matched wild type (WT) controls by immunohistochemical 
analysis. Cell proliferation was assessed by short-term 5-bromo-2'-deoxyuridine (BrdU)-
labeling of dividing cells. Absence of H2-Kb and H2-Db resulted in significantly more 
BrdU-positive proliferating cells (Figure 1B) and Doublecortin (Dcx)-positive 
neuroblasts in the DG of KD-/- mice compared to WT controls (Figure 1C). Interestingly, 
the number of Nestin-positive radial glial-like stem cells was not different between KD-/- 
and WT animals (Figure 1A), pointing to a regulatory role for H2-Kb and H2-Db during 
proliferative phases of adult neurogenesis. Additionally, I assessed neuronal 
differentiation and survival in a second cohort of mice using a long-term BrdU 
incorporation paradigm, in which post-migratory differentiated neurons co-express both 
BrdU and the mature neuronal marker NeuN. The number of BrdU/NeuN double-
positive differentiated mature neurons was increased in KD-/- compared WT mice 
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(Figure 1D). Given H2-Kb and H2-Db molecules are critical for immune cell development 
and function (Vugmeyster et al., 1998), I assessed microglia activation and detected no 
differences in the co-expression of ionized calcium-binding adapter molecule 1 (Iba1) 
and cluster of differentiation 68 (CD68) between dentate gyri of  KD-/- and WT mice 
(Figure S1A). Altogether, these data indicate that classical MHC I molecules, H2-Kb 
and H2-Db, negatively regulate cell proliferation and neurogenesis in the DG of the adult 
hippocampus. 
 
Regulation of NSPC proliferation by classical MHC I molecules 
Having observed the involvement of H2-Kb and H2-Db during the proliferative 
phases of neurogenesis in vivo, I next investigated the role of classical MHC I 
molecules in NSPC proliferation in vitro. I subdissected hippocampi from KD-/- and WT 
mice and cultured primary progenitor cells following an established protocol (Babu et al., 
2011). I characterized expression of H2-Kb and H2-Db mRNA by qPCR and H2-Kb 
protein by Western blot analysis in primary WT NSPCs, and confirmed absence of H2-
Kb and H2-Db expression in primary KD-/- NSPCs (Figure 1E; Figure S1B). Primary  
KD-/- and WT NSPCs were then cultured with growth factors EGF and FGF (self-
renewal conditions) and treated with the BrdU analog, 5-ethynyl-2´-deoxyuridine (EdU). 
I observed a significant increase in the percentage of EdU-positive proliferating cells in 
KD-/- compared to WT NSPCs (Figure 1F). To corroborate my findings in knockout 
NSPCs, I used a viral-mediated RNA interference (RNAi) approach. I generated 
lentiviral constructs encoding either short hairpin RNA (shRNA) sequences 
concomitantly targeting H2-Kb and H2-Db (sh-KD) or targeting luciferase as a control 
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(sh-control). Knockdown of H2-Kb and H2-Db expression was confirmed by Western blot 
and qPCR analysis in WT NSPCs expressing shRNA targeting H2-Kb and H2-Db 
compared to control shRNA (Figure 1G; Figure S1C). Consistent with knockout 
studies, acute abrogation of H2-Kb and H2-Db resulted in an increase in the percentage 
of EdU-positive proliferating cells compared to control conditions (Figure 1H). These in 
vitro results indicate that H2-Kb and H2-Db molecules inhibit NSPC proliferation.  
 
H2-Kb uniquely identified as a negative regulator of neurogenesis in the adult 
hippocampus in vivo and of NSPC proliferation in vitro 
Previous studies have ascribed H2-Kb and H2-Db with predominantly analogous 
functions in the brain (Shatz, 2009). Given the diversity of this family of molecules, I 
wanted to explore potential differential roles each may play in NSPC function. To test 
this possibility, I first analyzed a publicly available dataset describing the transcriptomic 
dynamics of early phase adult hippocampal neurogenesis at the single-cell level (Shin 
et al., 2015). Single-cell gene expression profiles were generated for Nestin-positive 
cells and their immediate progeny, with each cell bioinformatically assigned along a 
continuous trajectory from quiescent NSC activation to initiation of neurogenesis. 
Specifically, I divided the neurogenic lineage into an early time point (T1) where NSCs 
express glial fibrillary acidic protein (GFAP), and a later time point (T2) where 
differentiating intermediate neural progenitors begin to express T-box brain protein 2 
(Tbr2) (Figure 2A; Figure S2). Trendlines of H2-K1, H2-D1, and the proliferation 
marker Ki67 expression were fitted along this neurogenic trajectory (Figure 2A). 
Interestingly, as Ki67 expression increased H2-K1 expression decreased, while H2-D1 
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expression remained static (Figure 2A,B). Correspondingly, the frequency of cells 
expressing H2-K1 was significantly lower during T2 compared to T1, while no changes 
were observed for H2-D1, consistent with the housekeeping gene Gapdh (Figure 2B). 
These bioinformatics data suggest a potential preferential role for H2-Kb in regulating 
NSPC function during proliferative phase of adult neurogenesis.  
To investigate whether the exclusivity of H2-Kb, and not H2-Db, in regulating 
hippocampal neurogenesis can be verified in vivo, I utilized genetic mouse models in 
which H2-K1 (K-/-) or H2-D1 (D-/-) are individually excised. Neurogenesis was examined 
by immunohistochemistry in adult K-/-, D-/-, and WT mice. I observed a significantly 
higher number of Dcx-positive neuroblasts in the DG of K-/-, but not D-/- mice, compared 
to WT controls (Figure 2C,D). K-/- mice also displayed an increase in the number of 
long-term BrdU-retaining, neuronal nuclei (NeuN)-double positive mature differentiated 
neurons (Figure 2C,D). Nestin-positive radial glial-like stem cell numbers were not 
different between groups (Figure 2C,D), suggesting the influence of H2-Kb molecules is 
exerted during proliferative stages of neurogenesis rather than the stem cell pool.  
I then sought to delineate the individual functions of H2-Kb and H2-Db in 
regulating NSPC proliferation in vitro. Primary hippocampal NSPCs were isolated from 
K-/-, D-/-, and WT mice, then cultured under self-renewal conditions and treated with 
EdU. No differences in cell proliferation were observed in D-/- compared to WT NSPCs 
(Figure 2E). However, I detected a significant increase in the percentage of EdU-
positive proliferating cells in K-/- compared to WT NSPCs (Figure 2E), consistent with 
the bioinformatics analysis and in vivo genetic knockout model described above. 
Interestingly, under differentiation conditions in vitro, no differences in the percentage of 
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neurons and astrocytes were detected between genotypes (Figure S3A,B), suggesting 
a role for H2-Kb in specifically regulating the proliferative process in NSPCs in vitro. 
To complement the genetic mutant model, and circumvent potential 
developmental effects of a constitutive knockout, I next used an in vivo viral-mediated 
RNAi approach. I generated lentiviral constructs encoding either shRNA sequences 
targeting H2-Kb mRNA (sh-K) or targeting luciferase as a control (sh-control) (Figure 
3A). Adult WT mice were stereotaxically injected into the right DG with sh-K and into the 
left contralateral DG with sh-control (Figure 3A). Cell proliferation was assessed by 
short-term EdU-labeling and neuronal differentiation was assessed by long-term Brdu-
labeling. Local and temporally controlled knockdown of H2-Kb in the adult DG resulted 
in an increase in the number of EdU-positive proliferating cells, Dcx-positive 
neuroblasts, and BrdU/NeuN double-positive mature differentiated neurons (Figure 
3B,C) compared to the contralateral control within each animal. These results were 
supported by in vitro studies in cultured WT NSPCs, where I observed that acute 
abrogation of H2-Kb expression by sh-K resulted in a significant increase in EdU-
positive proliferating cells compared to control conditions (Figure 3D). Together, these 
data identify H2-Kb individually- out of as many as 50 MHC I subtypes - as a negative 
regulator of cell proliferation and neurogenesis in the hippocampus.  
 
Absence of H2-Kb may increase proliferation by altering cell cycle dynamics of 
NSPCs 
To gain insight into how H2-Kb influences NSPC proliferation, I again made use 
of the publicly available dataset described above (Figure 2A,B). I scored each single 
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cell analyzed for expression of signatures indicative of the G1/S or G2/M phases of the 
cell cycle (as described in Tirosh et al., 2016), and subsequently identified each cell as 
either positive or negative for H2-K1 expression (threshold: 5 CPM). I found that the 
percentage of cycling cells was significantly lower in H2-K1-positive cells (5%) versus 
H2-K1-negative cells (28.8%; p=0.0374, Fisher’s exact test), indicating NSCs and their 
immediate progeny are more likely to be non-cycling when enriched for H2-K1 (Figure 
4A,B). These bioinformatics data provides evidence that in an intact hippocampus, H2-
Kb regulates the proliferative potential of NSPCs possibly in a cell-intrinsic manner.  
Increased hippocampal NSPC proliferation is a phenomenon known to occur 
under certain stimuli; in the case of seizures, a shortened cell cycle length is the 
molecular mechanism underlying the enhancements in cell proliferation (Varodayan et 
al., 2009). I examined if similar changes occurred in cell-cycle dynamics of NSPCs 
lacking H2-Kb. Primary hippocampal NSPCs isolated from K-/- and WT mice were 
cultured under self-renewal conditions, and were subsequently treated with EdU at 2 
hour intervals over a 24-hour period. Absence of H2-Kb resulted in an increase in the 
ratio of proliferating cells to the total number of cells in the population, corresponding to 
the growth fraction (GF; Figure 4D). Furthermore, I observed a decrease in both the 
length of the S-phase (Ts) and length of the cell cycle (Tc; Figure 4D), calculated as 
described in Ponti et al., 2013. These in vitro data indicate that NSPCs lacking H2-Kb 
may show increased proliferation due to an acceleration of cell cycle progression.  
 
Transcriptome analysis identifies growth factor receptor-mediated signaling 
downstream of H2-Kb in NSPCs 
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To gain mechanistic insight into how MHC I molecules regulate NSPC 
proliferation, I profiled gene expression in primary NSPCs derived from K-/-, D-/-, KD-/-, 
and WT mice using RNA-sequencing. Abrogation of H2-K1 expression was 
corroborated in K-/- and KD-/- NSPCs (Figure S4A,B), in line with excision of Exon 2 and 
Exon 3 previously reported in these genetic models (Pérarnau et al., 1999). Hierarchical 
clustering revealed high similarity between biological replicates within individual 
genotypes (average Pearson Correlation Coefficient; PCC>0.99). Interestingly, 
replicates from K-/- NSPCs were segregated from all other genotypes (Figure 5A); 
further corroborated by differential expression analysis (DESeq2 adjusted p<0.05) 
between WT and individual knockout NSPCs (Figure 5C). As expected, we found a 
larger number of differentially expressed genes (844 genes) in K-/- NSPCs compared to 
D-/- (118 genes) or KD-/- (398 genes) NSPCs, with very few genes (13 genes) common 
between genotypes (Figure 5B). Taken together with the functional studies above, 
these transcriptional data further support H2-Kb as a distinct regulator of NSPC function.  
Next, I focused on genes whose expression was significantly different between 
WT and K-/- NSPCs. Among the most differentially upregulated genes detected in K-/- 
NSPCs, I found several growth factor and extracellular matrix protein encoding genes 
(Figure 5D); many of which are associated with increased NSPC proliferation (Chen et 
al., 2013; Lee et al., 2009; Rabenstein et al., 2015). Accordingly, I found “cell 
proliferation” among the most significantly enriched gene ontology (GO) terms. To 
elucidate pathways that might underlie increased proliferation observed in K-/- NSPCs, I 
performed pathway enrichment analysis (Figure 5E). Genes upregulated in K-/- NSPCs 
comprised several growth factor receptor-associated pathways, among these epidermal 
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growth factor receptor (EGFR) and fibroblast growth factor receptor (FGFR) signaling 
(Figure 5E).  Apoptosis pathway-associated genes did not differ between groups, 
whereas p53 tumor suppressor pathway genes were downregulated in K-/- NSPCs 
(Figure 5E). 
Western blot analysis confirmed that known receptor tyrosine kinase signaling 
pathways were more highly activated in K-/- compared to WT NSPCs. I assessed Akt 
and Erk pathways in WT and K-/- NSPCs grown under absent (0 ng/mL), low (5 ng/mL), 
or regular (20 ng/mL) growth factor conditions. Western blot analysis showed that 
enhanced phosphorylation of Erk (Thr202/Tyr204), but not Akt (Tyr450), occurred in K-/- 
NSPCs in low, non-saturating growth factor conditions (Figure 6A). Ribosomal protein 
S6, a downstream target of receptor tyrosine kinase signaling involved in cell 
proliferation, is also more highly phosphorylated  (Ser235/236) in K-/- NSPCs than WT 
NSPCs. Thus far, the results suggest that H2-Kb molecules negatively regulate cell 
proliferation through inhibition of receptor tyrosine kinase signaling pathways. 
 
H2-Kb forms macromolecular complex with specific growth factor receptors 
Intriguingly, receptors (such as insulin receptors and EGFRs) and other proteins 
have been shown to associate in cis with MHC I molecules, forming macromolecular 
complexes on the same cell surface (Arosa et al., 2007; Dixon-Salazar et al., 2014; 
Fehlmann et al., 1985; Schreiber et al., 1984). Given that these interactions can affect 
receptor signaling and internalization, I wanted to determine whether H2-Kb molecules 
could physically associate with the receptors revealed by transcriptomic analysis. 
Coimmunoprecipitation experiments were performed in mouse Neuro-2a (N2a) cells 
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exogenously expressing a FLAG-tagged H2-Kb and receptors that are highly expressed 
in NSPCs: EGFR, FGFR1, and FGFR3 (Figure 6B). Transfection of N2a cells with H2-
Kb and receptors, as well as antibody specificity, were confirmed by Western blot 
analysis of whole cell lysates (input lanes, Figure 6C-E). Anti-FLAG magnetic beads 
were used to immunoprecipitate H2-Kb along with its associated proteins. 
Immunoprecipitation of H2-Kb selectively coprecipitated FGFR1, but not FGFR3, EGFR, 
or the constitutively expressed protein GAPDH (IP lanes, Figure 6C-E). Thus, H2-Kb 
molecules are able to form macromolecular complexes with specific growth factor 
receptors known to be expressed on NSPCs.  
Correspondingly, I next investigated the functional role of FGFR signaling 
pathways in mediating the enhancement in proliferation previously observed in K-/- 
NSPCs. Primary NSPCs were isolated from hippocampi of K-/- and WT mice and 
cultured under self-renewal conditions in the presence or absence of a FGFR 
pharmacological inhibitor, PD161570. K-/- and WT NSPCs were then exposed to EdU 
and assessed for proliferation. While no differences in cell proliferation were observed in 
WT NSPCs at concentrations used for FGFR inhibitor treatment (Figure 6F), I detected 
a decrease in the percentage of EdU-positive proliferating cells in K-/- NSPCs exposed 
to PD161570 (Figure 6F). These data indicate that H2-Kb molecules negatively regulate 
NSPC proliferation by inhibiting FGFR-mediated signaling, potentially through a physical 
interaction with these receptors.   
 
Discussion 
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In this study, I identify classical MHC I molecule, H2-Kb, as a negative regulator 
of hippocampal neurogenesis. Using genetic mouse models as well as primary NSPC 
cultures, I show that deletion or knockdown of H2-Kb molecules causes increased 
proliferation and neurogenesis in the DG in vivo as well as in progenitor cells cultured in 
vitro. Subsequent transcriptome analysis of WT and K-/- NSPCs revealed that this 
enhanced proliferative potential is due to an enrichment of several growth factor 
receptor signaling pathways. I show also that H2-Kb is able to physically interact with a 
specific growth factor receptor, FGFR1, putatively modulating its signaling. My findings 
attribute H2-Kb a novel inhibitory function in NSPCs, describing for the first time a role 
for MHC I molecules in modulating cellular functions in a non-neuronal CNS cell type.  
To date, the inhibitory effects of MHC I have been described in neural processes 
such as neurite outgrowth, synaptogenesis, hippocampal and cerebellar synaptic 
plasticity, and activity-dependent refinement of developing visual system neurons 
(Glynn et al., 2011; Goddard et al., 2007; Huh et al., 2000; McConnell et al., 2009b). We 
have also previously shown that exogenous addition of β2-microglobulin, the non-
covalently associated subunit of the MHC I complex, can decrease the number of Dcx-
expressing neuroblasts in the adult hippocampus and negatively affect cognitive 
function (Smith et al., 2015). However, when β2-microglobulin was administered to mice 
lacking transporter associated with antigen processing 1 (Tap1), in which MHC I 
molecules cannot be trafficked to the cell membrane, the negative effects of β2-
microglobulin were mitigated. This suggested direct involvement of MHC I molecules in 
regulating hippocampal neurogenesis but the mechanisms remain unknown. These 
previous studies all investigated classical MHC I molecules in the CNS using broad 
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genetic manipulations, where β2-microglobulin, Tap1, or both were constitutively 
knocked out in the whole body. These models targeted MHC I as a whole class of 
molecules, as they decreased global cell surface expression of most if not all murine 
MHC I proteins indiscriminately. Because of the available genetic models, there has 
been a general assumption that classical MHC I subtypes performed analogous 
functions in the brain. However, as MHC I molecules comprise of a highly polymorphic 
gene family with over 50 sequences described, it is critical to begin to elucidate specific 
roles and cell-type significance for individual MHC I molecules in the CNS. Recently, it 
was shown that reintroduction of neuronal H2-Db alone could reverse synaptic deficits in 
KD-/- mice, suggesting that a single MHC I molecule was sufficient for functional 
synapse elimination and refinement in the visual system (Lee et al., 2014). 
Correspondingly, I examined involvement of H2-Kb and H2-Db separately in single 
knockout models and primary NSPCs derived from them. It should be noted that 
isolation of hippocampi from postnatal K-/- and D-/- mice may contain NSPCs from both 
the SGZ and SVZ, nor can oligodendrocyte precursors be excluded; thus, the 
proliferative effects observed may apply globally to other dividing cell populations in 
addition to hippocampal NSPCs. These data reveal a distinct role for H2-Kb in directing 
cell proliferation in vitro and hippocampal neurogenesis in vivo.  Additionally in this 
study, spatially- and temporally-controlled knockdown using RNAi in WT mice allowed 
me to separate the general effects of systemic immune compromise in genetic knockout 
models from the absence of H2-Kb specifically in the hippocampus. I found that while 
H2-Kb inhibits NSPC proliferation, H2-Db does not have an analogous role in NSPC 
function with few differences detected by in vivo histological analysis and NSPC RNA 
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sequencing of D-/- compared to WT animals. This functional difference may stem from 
disparities in structure, spatiotemporal distribution, or binding partners between H2-Kb 
and H2-Db, and further studies are required for detailed comparative characterization.  
My study also provides the first unbiased transcriptomic insight into pathways 
that may lie downstream of MHC I in the CNS. RNA sequencing analysis revealed 
enrichment of several growth factor receptor signaling pathways in K-/- NSPCs, 
identifying functional roles for FGFR, EGFR, PDGFR, and NGF signaling in mediating 
enhancements in proliferation. To date, many studies have shown that a number of 
soluble growth factors, such as insulin-like growth factor 1 (IGF1), vascular endothelial 
growth factor (VEGF), brain derived neurotrophic factor (BDNF), FGF2, and EGF 
regulate adult neurogenesis (Kuhn et al., 1997; Zigova et al., 1998; Lichtenwalner et al., 
2001; Cao et al., 2004). It has been further demonstrated that restoring growth factor 
signaling by increasing FGF2 or EGF in the neurogenic niche or activating FGFR in 
adult NSPCs is sufficient to enhance adult neurogenesis in rodents where aging or 
neurodegenerative disease has caused functional decline of stem cell function (Jin et 
al., 2003; Kang and Hebert, 2015; Woodbury and Ikezu, 2014). It is promising that 
despite pathological neurogenic decline, the remaining endogenous NSPCs are 
amenable to rejuvenation through activation of growth factor signaling. Further insights 
into precisely how physical interactions between H2-Kb and growth factor receptors 
affect their trafficking dynamics, internalization, and signaling specifically on NSPCs will 
first be required to better understand how H2-Kb can be therapeutically targeted.  
Under physiological conditions, neurogenesis has been implicated in spatial 
learning and memory, pattern separation, and affective behaviors (Ming and Song, 
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2011). Although tightly controlled, this process is highly vulnerable under pathological 
conditions: in mammalian models NSPC loss of function occurs in aging and 
neurodegenerative disorders while aberrant gain of NSPC proliferation can occur in 
epilepsy and schizophrenia (Haughey et al., 2002; Kuhn et al., 1996; Parent et al., 
1997; Toro and Deakin, 2007; van Wijngaarden and Franklin, 2013). Preventing NSPC 
dysfunctions may be essential for restoring brain functions under pathological 
conditions, and identification of specific molecules and mechanisms controlling 
neurogenesis will inform translational efforts. H2-Kb is an attractive therapeutic target as 
MHC I molecules have been implicated in several CNS and systemic diseases —many 
of which present with NSPC dysfunction— by human genome-wide association studies 
(GWAS). Single nucleotide polymorphisms on the MHC complex region on 
chromosome 6 have been linked with highly significant disease risk in schizophrenia 
and age-associated disorders (International Schizophrenia Consortium et al., 2009; 
Jeck et al., 2012; Shi et al., 2009; Stefansson et al., 2009). In addition to a genetic 
association to disease, MHC I expression has directly been shown to be dynamic in 
certain pathophysiological states: MHCI molecules increase in rodent hippocampal 
neurons and neuromuscular junctions with age, interfering with synaptic homeostasis 
(Starkey et al., 2012; Tetruashvily et al., 2016), and an upregulation of neuronal H2-Kb, 
H2-Db, and MHC I receptor, PirB, is observed in stroke (Adelson et al., 2012). As 
animals lacking H2-Kb and H2-Db are protected from tissue damage and exhibit 
enhanced motor recover after stroke (Adelson et al., 2012), it remains for further studies 
to test whether targeting H2-Kb molecules in the aging hippocampus could prevent or 
reverse age-related neurogenic decline.  
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 In summary, these studies have identified classical MHC I molecule H2-Kb as an 
inhibitor of NSPC proliferation and hippocampal neurogenesis. Adult animals with a 
genetic deletion or acute knockdown of H2-Kb in the DG exhibit enhanced cell division 
and increased adult-born neurons in the hippocampus. A hyper-proliferative phenotype 
is also observed in cells isolated from the postnatal K-/- brain and cultured in vitro, 
devoid of influences from the neurogenic niche or systemic environment. RNA 
sequencing of WT and K-/- NSPCs further revealed that H2-Kb reduces proliferation by 
dampening growth factor receptor signaling pathways. As many CNS disorders with 
neurogenic dysfunction also co-exhibit changes in MHC I expression, these results 
revealing the direct functional contribution of H2-Kb in NSPC function may help in 
illuminating new pathways to target in their treatment.  
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Figure 1. Deletion of classical MHC I molecules, H2-Kb and H2-Db, increases 
hippocampal neurogenesis and NSPC proliferation. Representative field and 
quantification of Nestin+ neural stem cells (NSCs) in the dentate gyrus (DG) of adult (3 
months) WT and H2-Kb/H2-Db double knockout (KD-/-) mice (A). Representative field 
and quantification of BrdU+ dividing cells (B) and Dcx+ neuroblasts (C) in the DG of adult 
WT and KD-/- mice. A second cohort of adult WT and KD-/- mice were injected with 6 
days of BrdU and differentiated cells co-expressing long-term retained BrdU (BrdU-long) 
and the mature neuronal marker NeuN in the DG were visualized and quantified 4 
weeks later. Inset shows higher magnification of a double-labeled cell, indicated by 
arrow (D). Primary hippocampal neural stem and progenitor cells (NSPCs) were 
isolated from WT and KD-/- post-natal mice. Confirmation of knockout and specificity of 
our anti-H2-Kb antibody was assessed by Western blot analysis of WT and KD-/- NSPC 
lysates (E). See also Fig. S1B for H2-Kb and H2-Db mRNA expression. Primary 
hippocampal WT and KD-/- NSPCs were cultured under self-renewal conditions and 
treated with 5-ethynyl-2´-deoxyuridine (EdU) for 6 hours. Representative field and 
percentage of EdU+ dividing cells are shown (F). WT NSPCs were infected with 
lentiviruses encoding shRNA concomitantly targeting H2-Kb and H2-Db (sh-KD) or 
targeting luciferase as a control (sh-control). Knockdown was confirmed by Western blot 
analysis of sh-KD and sh-control NSPC lysates probed with anti-H2-Kb and anti-GAPDH 
antibodies. See also Fig. S1C for H2-Kb and H2-Db mRNA expression. WT NSPCs 
infected with lentiviruses encoding sh-KD and sh-control were cultured under self-
renewal conditions and treated with EdU for 6 hours. Representative field and 
percentage of EdU+ dividing cells are shown (H). Scale bars, 100µm (A-C) and 50µm 
(E,G). WT n = 5, KD-/- n=4-5 for histological analysis; n=3 replicates per group for in 
vitro experiments. All data are represented as mean ± SEM; *p<0.05. Student’s t-test 
(A-G). 
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Figure 2. H2-Kb, but not H2-Db, negatively regulates hippocampal neurogenesis 
and NSPC proliferation. Relative expression of H2-K1, H2-D1 and Mki67 along a 
bioinformatically assigned trajectory of adult neurogenesis. Single adult hippocampal 
NSCs were ordered according to pseudotime (x-axis) estimates as given in (Shin et al., 
2015). Relative gene expression (y-axis, log2(CPM+1)/max(log2(CPM+1))) was fitted 
with local polynomial regression fitting (bold lines) with 95% confidence interval (light 
colored area). The cutoff point between time points T1 and T2 was determined by the 
time of increasing Tbr2 expression (last stationary point of the Tbr2 regression line; see 
Fig. S2) (A). Number of cells positive (CPM>5) for H2-K1, H2-D1, Ki67 and Gapdh 
expression (y-axis) between T1 and T2 (B). Representative field (C) and quantifications 
(D) of Nestin+ NSCs, Dcx+ neuroblasts and adult-born neurons co-expressing BrdU-long 
and NeuN in the DG of 3-month-old WT, H2-Kb knockout (K-/-), and H2-Db knockout    
(D-/-) mice. Primary hippocampal WT, K-/-, and D-/- NSPCs cultured under self-renewal 
conditions were treated with EdU for 6 hours. Representative field shown and mean 
percentage of EdU+ dividing cells were quantified (E). Scale bars, 50µm (C) and 100µm 
(E). WT, n=5; K-/-, n=5; D-/-, n=5 for histological analysis; n=3 replicates per group for in 
vitro experiments. Data are represented as mean ± SEM; *p<0.05, **p<0.01, 
***p<0.001. Fisher’s exact test (B); ANOVA with Dunnett’s post hoc test (D, E). 
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Figure 3. Acute abrogation of H2-Kb increases adult hippocampal neurogenesis in 
vivo and NSPC proliferation in vitro. Schematic illustrating vector map of lentivirus 
encoding an H1 promoter-driven short hairpin RNA (shRNA) targeting H2-Kb (sh-K) or 
luciferase as a control (sh-control) in tandem with a GFP reporter. Adult (3 months) WT 
mice were stereotaxically injected with sh-K in one DG and sh-control in the 
contralateral DG (A). Representative field of Dcx+ neuroblasts, EdU+ dividing cells, and 
cells infected with the lentivirus, as visualized by the GFP reporter (B). Quantification of 
EdU+ proliferating cells, Dcx+ neuroblasts, and BrdU-long/NeuN double-positive mature 
neurons in sh-K injected DG compared to the contralateral control-injected DG. Data 
represented as mean Log2 fold change over control ± SEM (C). WT NSPCs infected 
with lentiviruses encoding sh-K and sh-control were cultured under self-renewal 
conditions and treated with EdU for 6 hours. Representative field and percentage of 
EdU+ dividing cells are shown. Data represented as mean number of cells per field ± 
SEM (D). Scale bars, 50µm (B), 100µm (D). n=6 mice for histological analysis of 
stereotaxically-injected mice; n=3 replicates per group for in vitro experiments. *p<0.05, 
**p<0.01; Student’s t-test (C, D). 
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Figure 4. H2-Kb regulates cell cycle dynamics at the cell autonomous level.  A 
publicly available dataset of single adult hippocampal NSCs (Shin et al., 2015) was 
sorted by expression of G1 (x-axis) and G2 (y-axis) cell cycle scores as described in 
Tirosh et al. 2016. Cells positive for H2-K1 expression (>5 CPM) are indicated in red 
(A). The percentage of cycling cells was found to be significantly lower in H2-K1-positive 
cells (5%) versus H2-K1-negative cells (28.8%); p=0.0374, Fisher’s exact test (B). 
Primary hippocampal WT and K-/- NSPCs cultured under self-renewal conditions were 
treated with EdU at 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, or 24 hours (hrs) prior to 
fixation, and percentage of EdU+ cells was determined by flow cytometry. Percent of 
cells incorporating EdU reached a plateau at 13.47 hrs for WT NSPCs and 13.24 hrs for 
K-/- NSPCs (Tc-Ts) when the cycling population (GF) entered the S phase. Linear 
regression for increasing phase of WT NSPCs: y = 0.6133 x + 7.996; R2=0.829 and K-/- 
NSPCs: y = 1.165 x + 7.406; R2= 0.889. Values for cell cycle parameters calculated 
from cumulative labeling are shown in the right panel. GF, growth fraction; Tc, length of 
cell cycle; Ts, length of S phase (C). n=2 replicates. Data represented as mean ± SEM; 
*p<0.05, **p<0.01, ***p<0.001. Two-way repeated measures ANOVA with Sidak’s post 
hoc test (C). 
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Figure 5. RNA-sequencing identifies growth factor receptor-mediated signaling 
downstream of H2-Kb in NSPCs. Pairwise distances (Euclidean distance) between 
RNA-sequencing libraries prepared from WT, KD-/-, K-/-, and D-/- primary hippocampal 
NSPCs. Dendrogram was calculated by unsupervised hierarchical clustering (average 
linkage). (WT, n=3 replicates [denoted R1-R3]; KD-/-, n = 2 replicates; K-/-, n=3 
replicates; and D-/-, n=3 replicates) (A). Venn diagram illustrating genes differentially 
expressed (DEGSeq2 adj. p<0.05) between WT, KD-/-, K-/-, and D-/- NSPCs (B). 
Scatterplot of the average gene expression in WT (x-axis) and K-/- (y-axis) NSPCs (C). 
Differentially expressed genes (DEGSeq2 adj. p<0.05, 432 down and 408 upregulated) 
are indicated in red. Genes shown in heatmap (D) are colored in blue. Unsupervised 
hierarchical clustering of RNA-seq libraries (columns) in the space of genes indicated in 
(C) (z-score normalized, rows) (D). Cellular and signaling pathways identified by 
pathway enrichment analysis (ConsensusPathDB) of genes differentially expressed 
between WT and K-/- NSPCs are subdivided in gray. Outer ring illustrates expression of 
altered genes (log2 fc K-/- vs WT) within each pathway. Inner ring illustrates significance 
(-log10 adj. p-val) and overall expression levels of genes within each pathway (z-score) 
(E). 
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Figure 6. H2-Kb inhibits growth factor receptor signaling pathways in NSPCs 
through the formation of macromolecular complexes with receptors. Western blot 
analysis of activated Akt, Erk, and ribosomal proteign S6 in WT and K-/- NSPCs grown 
under absent (0 ng/mL), low (5 ng/mL), or regular (20 ng/mL) growth factor conditions 
(A). Schematics of lentiviral vectors generated for N2a cell transfection in co-
immunoprecipitation experiments (D-E): CMV promoter-driven 3x-FLAG-tagged H2-K1, 
Fgfr1, Fgfr3, and Egfr (B). N2a cells were co-transfected with 3xFLAG H2-K1 and Fgfr1 
(C), Fgfr3 (D), or Egfr1. Anti-FLAG magnetic bead selectively co-precipitate FGFR1, but 
not FGFR3, EGFR, or intracellular proteins (GAPDH). Primary hippocampal WT (left 
panel) and K-/- (right panel) NSPCs were exposed to fibroblast growth factor receptor 
inhibitor PD 161570 (PD, 0.1uM or phosphate-buffered saline control for one hour and 
subsequently treated with EdU for 6 hours to test for proliferation (F). Data represent as 
mean percentage of EdU+ cells per field ± SEM. n=3 replicates per group for in vitro 
experiments; *p<0.05. ANOVA with Dunnett’s post hoc test (F).  
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Figure S1. Characterization and validation of MHC I knockout and knockdown in 
vivo and in vitro models. Representative field and quantification of ionized calcium-
binding adapter molecule 1 (Iba1) and cluster of differentiation 68 (CD68) mean 
intensity in the DG of adult WT and KD-/- mice (A). Quantitative RT-PCR of H2-Kb (left 
panel) and H2-Db (right panel) mRNA from primary NSPCs isolated from WT, KD-/-, K-/-, 
and D-/- mice (B). Quantitative RT-PCR of H2-Kb (left panel) and H2-Db (right panel) 
mRNA from primary WT NSPCs infected with lentiviruses encoding shRNA targeting 
H2-Kb and H2-Db (sh-KD), H2-Kb (sh-K), or luciferase as a control (sh-cntl). Scale bars, 
50µm (A). WT n=5, KD-/- n=4 for histological analysis; n=3 replicates per group for in 
vitro experiments. All data represented as mean ± SEM; **p<0.01, ****p<0.0001. 
Student’s t test (A), ANOVA with Dunnett’s post hoc test (B, C). 
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Figure S2, related to Figure 2. Single-cell transcriptomic characterization of H2-K1 
expression during neurogenesis. Relative expression of Tbr2 along a trajectory of 
adult neurogenesis, as described in Figure 2A. The cutoff point between time points T1 
and T2 was determined by the time of increasing Tbr2 expression (last stationary point 
of the Tbr2 regression line).   
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Figure S3. No apparent alteration in neuronal differentiation potential in NSPCs 
lacking H2-Kb or H2-Db.  WT, K-/-, and D-/- NSPCs were cultured under growth factor-
free conditions and allowed to differentiate for 6 days. Representative field (A) and 
quantification (B) of microtubule-associated protein 2-positive (Map2+) neurons and glial 
fibrillary acidic protein-positive (GFAP+) astrocytes. Data represented as mean 
percentages ± SEM; n=3 replicates per group. ANOVA, with Dunnett’s post hoc test (B).  
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Figure S4, related to Figure 5. Validation of H2-Kb knockout in primary NSPCs by 
RNA-sequencing analysis. Normalized (Log2(CPM=1)) RNA-sequencing expression 
of H2-K1 (y-axis) in WT (n=3 replicates), KD -/- (n=2), K-/- (n=3), and D-/- (n=3) primary 
hippocampal NSPCs (A). Interactive Genome Viewer (Broad Institute) Sashimi plot 
visualizing RNA-sequencing read density (colored areas) and junction-spanning reads 
(lines) in WT (bottom) and K-/- NSPCs (B). K-/- NSPCs are devoid of reads mapping to 
exons 2 or 3. Junction spanning reads map from exon 1 to exon 4.  
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Chapter 4 
Role of Classical MHC I Molecules in Regulating Cognitive 
Function 
 
In order to translate experience into behavioral change and memory, neural 
plasticity resulting in the selective strengthening and weakening of appropriate 
synapses must occur. A surprising regulator of synaptic plasticity in the hippocampus 
are major histocompatibility complex class I (MHC I) molecules, as animals deficient for 
cell surface expression of these proteins display enhanced long-term potentiation (LTP) 
and absent long-term depression (LTD). LTP and LTD mechanisms comprise the 
cellular basis of experience-dependent development, learning and memory, and their 
impairments are prominent in neurological disorders. To date, it remains to be 
elucidated how individual MHC I molecules (of the more than 50 encoded in the mouse 
genome) function to regulate learning and memory. Here I test mice genetically lacking 
each of the classical MHC I molecules, H2-Kb or H2-Db, individually (K-/- and D-/- mice, 
respectively) in a battery of behavioral tests. This study demonstrates that D-/- mice 
exhibit impairments in locomotion, anxiety-related behavior, and hippocampus-
dependent spatial and contextual memory. Remarkably, I show that acute ablation of 
H2-Db in the adult hippocampus, using an RNA interference approach, can improve 
hippocampus-dependent memory. My results establish the developmental necessity of 
one specific MHC I molecule, H2-Db, in maintaining intact cognition and show a 
potential for the therapeutic targeting of this molecule in CNS disorders that present with 
hippocampal dysfunction. 
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Introduction 
 Pleiotropy—where one protein can drive multiple, apparently unrelated 
phenotypic features in different tissues or cell types— is a feature prominent in a 
growing number of molecules first characterized in the immune system. Many proteins 
first discovered to have immune roles have since been detected in the healthy 
developing and adult central nervous system (CNS), and additionally demonstrated to 
have non-canonical roles in regulating nervous system development, refinement, and 
plasticity (Boulanger, 2009). One particular class of molecules, major histocompatibility 
complex class I (MHC I), play a role not only in the early establishment of appropriate 
connectivity and synaptic properties of developing neurons (Bilousova et al., 2012; 
Datwani et al., 2009; Glynn et al., 2011; Huh et al., 2000), but also influence the later 
structural and functional synaptic plasticity of the CNS that is malleable throughout life 
(Fourgeaud et al., 2010; Goddard et al., 2007; Huh et al., 2000; McConnell et al., 
2009b).  
 Plasticity at the synapse, in the form of long-term potentiation (LTP) or long-term 
depression (LTD), is thought to underlie behavioral change through the selective 
strengthening or weakening of pertinent synapses (Bliss and Collingridge, 1993; 
Kessels and Malinow, 2009). Adult hippocampal plasticity occurs when repetitive, 
coincident depolarization of a set of synapses causes activation of N-methyl-D-
aspartate (NMDA)-type glutamate receptors, resulting in subsequent changes to the 
trafficking and function of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA)-type glutamate receptors. A large magnitude, transient activation of NMDA 
receptors leads to LTP via AMPA receptor insertion, whereas weak, persistent 
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activation of NMDA receptors induces removal of AMPA receptors resulting in LTD. The 
result is a long-lasting modification of synaptic strength between two or more synapses 
involved in the circuit. There is an abundance of data supporting the notion that intact 
synaptic plasticity is necessary for learning and memory (see Martin et al., 2000 for an 
extensive review): impairments to hippocampus-dependent spatial and associative 
memory were observed in animals with genetic or pharmacological disruptions in LTP 
(Mayford et al., 1996; Morris et al., 1986) and conversely, manipulations that facilitate 
the induction of LTP have been shown to enhance memory formation (Lynch, 1998; 
Seabrook et al., 1997). Synaptic plasticity mechanisms are also critical during early 
activity-dependent pruning and elimination of neural circuitry and impairments in 
synaptic plasticity mechanisms are a hallmark of many neuropsychiatric disorders as 
well as in the aging brain (Barnes, 2003; Kolb and Gibb, 2011; Lau and Zukin, 2007). 
Identifying novel molecular mechanisms that control synaptic plasticity will help further 
elucidate the neural basis of normal cognition and reveal potential targets in 
pathological brain function.  
 MHC I molecules first appeared as unexpected regulators of CNS function in an 
unbiased screen for genes involved in activity-dependent synaptic remodeling of the 
mammalian visual system (Corriveau et al., 1998). MHC I mRNA is highly expressed in 
brain regions exhibiting continuous plasticity, such as the adult hippocampus, and its 
expression levels are dynamically regulated by the activity state of the neuron 
(Corriveau et al., 1998; Huh et al., 2000); these attributes make them prime candidates 
for the modulation of synaptic transmission between neurons. Indeed, transgenic mice 
lacking β2-microglobulin (β2m), the non-covalently bound light chain of the MHC I 
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complex, and the transporter associated with antigen processing 1 (Tap1), which 
transports peptides across the endoplasmic reticulum membrane, have been studied in 
this context. MHC class I is a large gene family and this double knockout model (β2m-/- 
Tap1-/-) broadly reduces cell-surface expression of the more than 50 MHC I molecules 
expressed in the murine genome (Ljunggren et al., 1995). β2m-/-Tap1-/- mice display 
enhanced high-frequency stimulation-induced LTP and absent low-frequency 
stimulation-induced LTD in the CA1 of the hippocampus (Huh et al., 2000; Nelson et al., 
2013), mediated by enhanced NMDA receptor-mediated currents and subsequent 
increase of AMPA receptors at the cell surface (Fourgeaud et al., 2010). As acquisition 
and consolidation of explicit memories is believed to require NMDA-dependent LTP and 
LTD in the hippocampus, surface MHC I-deficient mice were tested for hippocampal-
dependent learning and memory. Despite increased synaptic potentiation via relief of 
inhibition by MHC I, β2m-/-Tap1-/- mice performed worse than wild-type (WT) littermates 
in contextual fear conditioning and object or social recognition tests of memory (Nelson 
et al., 2013). These broad models of surface MHC I abrogation provide convincing, 
though indirect, evidence of the necessity of these molecules in modulating 
hippocampal plasticity and associated behaviors. To date, it remains to be elucidated 
how individual MHC I molecules (of the more than 50 encoded in the mouse genome) 
function in the CNS. To directly tease apart the roles specific MHC I molecules play in 
the regulation of hippocampus-dependent cognition, I tested mice genetically lacking 
each of the classical MHC I molecules, H2-Kb or H2-Db, individually (K-/- and D-/- mice, 
respectively) in a battery of behavioral tests. To complement these constitutive genetic 
knockout models, I also used a lentivirus-mediated short hairpin RNA (shRNA) 
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approach to knockdown H2-Kb or H2-Db with spatiotemporal precision in the 
hippocampus. Together, these results demonstrate the developmental necessity for a 
single MHC I molecule, H2-Db, in preserving normal locomotion, anxiety-related 
behavior, and spatial memory, and furthermore show that its acute ablation in the adult 
hippocampus can remarkably improve hippocampus-dependent memory.  
 
 
Results 
Animals lacking H2-Db have abnormal nesting, locomotor, and anxiety 
phenotypes 
To elucidate the roles H2-Kb and H2-Db may play in regulating cognitive function, 
I made use of mice genetically lacking H2-Kb (K-/-) or H2-Db (D-/-) individually. In order to 
characterize these mice and to exclude potential developmental or motor deficits that 
may confound cognitive testing, general behaviors such as home cage nest forming, 
locomotor activity, and anxiety were tested in 3 month old WT, K-/-, and D-/- mice. 
Nesting scores (on a 4-point scale, Figure 1A) were recorded two hours after mice 
were individually housed and given a fresh nestlet. D-/- mice had significantly lower 
nesting scores at 2 hours than WT or K-/- mice (Figure 1B). However, these differences 
disappeared after 24 hours as D-/- mice could eventually form nests like the other 
groups, suggesting delayed but otherwise normal home cage daily living behavior. In 
the open field test, D-/- mice exhibited increased total locomotor activity but no 
differences in time spent in the center of the field compared to WT and K-/- mice. In the 
elevated zero maze, a test specifically for anxiety, D-/- mice spent twice as much time in 
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the open, exposed arms of the maze as K-/- and control mice did (Figure 1F). The 
increased locomotor phenotype of D-/- mice seen in the open field was recapitulated in 
the elevated zero maze (Figure 1E). These behavioral phenotyping data suggest D-/- 
mice have heightened locomotor or exploratory activity levels and an attenuated anxiety 
response, whereas performance in K-/- mice is indistinguishable from WT mice. 
 
Animals lacking H2-Db have impaired spatial and fear memory 
Hippocampal slices from mice lacking surface expression of MHC I molecules 
(β2m-/-Tap1-/-) have previously been shown to exhibit enhanced LTP and absent LTD 
after tetanic stimulation of the Schaffer collaterals (Huh et al., 2000; Nelson et al., 
2013). Given that genetic and pharmacological manipulations that affect hippocampal 
LTP are bidirectionally correlated with changes in spatial memory (Martin et al., 2000), it 
naturally follows that I tested WT, K-/-, and D-/- mice for hippocampal-dependent learning 
and memory using the radial arm water maze (RAWM) and contextual fear conditioning. 
3-month-old WT, K-/-, and D-/- mice were tested in a six-arm maze in two-day paradigm, 
with the first (training) day consisting of 12 alternating visible and hidden trials followed 
by 3 hidden trials, and the second (testing) day consisting of 15 hidden trials (Figure 
2A,B). A decrease in errors made is indicative of learning and memory of the task. K-/- 
mice did not exhibit any differences in number of errors made compared to WT mice on 
either day (Figure 1C). Surprisingly, D-/- mice performed worse, both in short-term 
learning (last block on Day 1) and memory (Day 2), when compared to WT mice 
(Figure 2D).  
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An associative learning task, fear conditioning, was also used to assess 
hippocampus-dependent and independent memory in K-/-, D-/-, and WT mice. In this 
two-day paradigm, mice were exposed to two pairings of an unconditioned stimulus 
(foot shock) with conditioned stimuli (tone and context) on the first day, and tested for 
contextual and cued memory manifested as freezing behavior on the second day 
(Figure 3A). At baseline D-/- mice froze less during the first two minutes of exposure to 
the chamber (prior to presentation of tone and shock) on the training day (Figure 3B), 
reiterating the hyperactive phenotype seen in the open field and elevated zero maze 
task (Figure 1C,E). To account for baseline differences, net freezing during the 
contextual and cued tasks was calculated by subtraction of baseline freezing from 
freezing during each test on Day 2. Impaired hippocampus-dependent contextual 
memory— in which mice were placed in the same chamber as during training— was 
observed in both K-/- and D-/- mice (Figure 3C). Mice were then tested for cued auditory 
memory, which is not hippocampus-dependent but rather contingent on intact amygdala 
function, after the conditioned tone is played in a chamber with different walls, floor, and 
scent. There is a direction of change towards less freezing for the auditory conditioned 
stimulus for both K-/- and D-/- mice, though not statically significant (Figure 3D). Intact 
cued conditioning in K-/- and D-/- mice suggests that their impaired contextual memory 
was not due to an inability to freeze or a problem with the amygdala, but specifically 
implicated hippocampal involvement. These results, combined with the phenotypes 
observed in RAWM, begin to discern the individual roles H2-Kb and H2-Db might play in 
regulating specific types of behavior and memory. In additional to locomotor and anxiety 
phenotypes, mice lacking H2-Db appear to be more severely impaired in both 
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hippocampal-dependent spatial and associative memory tasks tested compared to WT 
mice, whereas K-/- mice are only impaired in the contextual fear conditioning task.   
 
Acute abrogation of H2-Db improves spatial learning and memory 
Targeted deletion of specific genes offers an invaluable tool for studying the roles 
of those molecules in a biological pathway or system. However, as genetic K-/- and D-/- 
mouse models are constitutive, whole-body knockouts, potential for developmental 
compensation or contribution of other cell types should not be overlooked and can be 
addressed by using complementary methods to probe the roles of H2-Kb and H2-Db in 
the brain. To this end, I next used an in vivo viral-mediated RNA interference approach 
to gain spatial and temporal control over the abrogation of H2-Kb or H2-Db. I generated 
lentiviral constructs encoding either shRNA sequences targeting H2-Kb mRNA (sh-K), 
H2-Db mRNA (sh-D) or targeting luciferase as a control (sh-control) (Figure 4A). 2 to 
2.5 month old WT mice were bilaterally stereotaxically injected into the hippocampal 
dentate gyrus (DG) with sh-control, sh-K, or sh-D (Figure 4B) and behavioral testing 
was started when animals were between 3 to 3.5 months of age. Spatial distribution of 
the lentivirus in the hippocampus was verified by lentivirally-encoded GFP (LV-GFP) 
localization in fixed brain tissue (Figure 4C). Efficacy of shRNA knockdown was 
validated in mouse neuro2A cells: Western blot analysis confirmed knockdown of H2-Kb 
protein (Figure 4D,E) versus control shRNA, and due to lack of a specific antibody, H2-
Db knockdown was confirmed by qPCR (Figure 4F). 
Local and temporally controlled knockdown of neither H2-Kb nor H2-Db in the 
adult DG caused differences in open field behavior, with all groups displaying similar 
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total distance travelled and center time (Figure 5A,B). In the elevated zero maze test 
for anxiety, sh-D-injected mice appeared to spend more time in the open arm, though 
the variance was high and this result was not statistically significant (Figure 5C). With 
similar baseline measures of activity confirmed, I proceeded to test if acute knockdown 
of H2-Kb or H2-Db in the DG would specifically affect hippocampal-dependent learning 
and memory in the RAWM and contextual fear conditioning paradigms. 
Adult mice with a spatiotemporally specific knockdown of H2-Kb in the DG did not 
exhibit differences in errors made compared to control-injected animals in either 
learning or testing days of the RAWM (Figure 6A), suggesting hippocampal H2-Kb is 
not necessary for intact spatial memory. In contrast to H2-Db knockout mice, which had 
severely compromised spatial memory, temporally controlled knockdown of H2-Db in the 
DG caused significant improvements in the RAWM, with a notable decrease in errors 
occurring during testing on Day 2 (Figure 6B). These results highlight the ability of one 
molecule, H2-Db, to be detrimental for learning and memory when completely abrogated 
throughout development but to become beneficial when partially knocked down acutely 
in an adult mouse, implying that timing or degree of the manipulation is important. 
Despite robust differences in RAWM, neither sh-K nor sh-D-injected mice exhibited 
differences in baseline, contextual, or cued freezing behaviors compared to control-
injected mice in fear conditioning (Figure 7A-C).  
Altogether, these results clearly reveal a role for H2-Db in the regulation of 
locomotion, anxiety behavior, and hippocampus-dependent memory. Interestingly, while 
complete loss of H2-Db during development is detrimental for spatial learning and 
memory, an acute knockdown specifically in the DG of an otherwise healthy, young 
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mouse considerably improves its hippocampal-dependent learning. Contrarily, H2-Kb 
appears not to be necessary for normal locomotion, anxiety behavior, or spatial learning 
in the RAWM as K-/- mice behaved similarly to WT mice in all tasks except associative 
fear conditioning. Acute knockdown of H2-Kb elicited no differences in spatial or 
contextual association memory. Whether or not these differences imply differential 
distributions, mechanisms, or cell types involved between H2-Kb and H2-Db remain to 
be further elucidated.  
Although spatiotemporal resolution was gained by using an acute RNA 
interference approach, obtaining cell-type specificity of knockdown was not achievable 
with a lentiviral-mediated shRNA approach. To complement the genetic and lentiviral 
approaches, we collaborated with Applied StemCell, Inc. to generate conditional H2-Db 
knockout mice in order to study how manipulation of the molecule on specific brain cell 
types will alter cognitive behaviors in future studies.  
 
 
 
Discussion 
 
Here I demonstrate that the presence of H2-Db throughout development is 
required for normal locomotor activity, normal anxiety-related behavior, and spatial and 
contextual memory. These findings recapitulate the results of a previous study (Nelson 
et al., 2013) revealing hippocampus-dependent memory impairments in β2m-/-Tap1-/- 
mice, but importantly, further reveal the specificity of one individual MHC I molecule in 
regulating hippocampal cognition. Intriguingly, though full-body, constitutive D-/- mice 
display marked behavioral abnormalities, acute knockdown of H2-Db localized to the 
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hippocampus results in improved spatial learning and memory compared to WT 
baseline levels.  
Previously, the neuroimmune field has made use of broad genetic models such 
as the β2m-/- Tap1-/- double knockout mouse to study the role of MHC I molecules as a 
family in CNS function. However, the conclusions drawn about the necessity of MHC I 
molecules in maintaining synaptic development and plasticity are indirect because β2m 
and Tap1 are needed only for stable expression of MHC I at the cell surface. This model 
also indiscriminately decreases surface expression of the up to 50 MHC I proteins found 
in the murine genome. To provide insights into specificity, subsequent studies have 
utilized mice with genetic deletions of just the two classical MHC I molecules, H2-Kb and 
H2-Db (KD-/-). These studies observed plasticity abnormalities in the form of expanded 
retinogeniculate projections, increased ocular dominance plasticity, extensive cortical 
connectivity, increased synapse density, and lack of LTD in KD-/- mice (Adelson et al., 
2016; Datwani et al., 2009; Dixon-Salazar et al., 2014; Lee et al., 2014). In situ 
hybridization experiments have shown that both H2-Kb and H2-Db transcripts are 
present in many regions of the brain and that their spatial expression patterns parallel 
each other, though the signal of H2-Kb mRNA is much lower (Huh et al., 2000). This has 
led to a general assumption that H2-Kb and H2-Db perform analogous functions in the 
CNS. Recently, Lee et al. showed that the neuronal reintroduction of just H2-Db in KD-/- 
mice was sufficient to restore synapse elimination and LTD deficits at retinogeniculate 
synapses back to WT levels (Lee et al., 2014). This result was the first time the role of 
an individual MHC I protein in the CNS was discerned, though the sufficiency of H2-Kb 
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or other MHC I molecules were not tested, nor was the role of neuronal H2-Db in 
cognitive function.  
 The presence of H2-Db, through its modulation of the calcium-permeability of 
AMPA receptors, appears to be necessary for maintaining LTD at synapses in the 
retinogeniculate system (Lee et al., 2014). H2-Db is also highly expressed in the 
hippocampus, a brain structure of immense neuroplastic potential. Taken along with the 
findings showing increased hippocampal LTP and absent LTD in β2m-/-Tap1-/- mice, it 
stands to reason that H2-Db molecules may similarly regulate LTP and LTD 
mechanisms with consequences in behavioral output. Synaptic plasticity in the 
hippocampus is widely thought to be a candidate mechanism for certain types of long-
term memory, including those of spatial and contextual nature. My study elucidates for 
the first time a developmental necessity of specifically H2-Db in not only hippocampus-
dependent learning and memory but also in locomotor and anxiety-related behaviors. 
Because the general discourse of the literature suggests that plastic changes in the 
brain support improved cognitive functions, one might expect MHC I-deficient mice, 
which show augmented hippocampal LTP, to exhibit enhancements in relevant learning 
and memory tasks. Additionally, there is direct evidence that mice lacking both H2-Kb 
and H2-Db have enhanced motor learning on the rotarod due to altered cerebellar 
plasticity (McConnell et al., 2009b). I found instead that D-/- mice were impaired in both 
hippocampus-dependent memory tasks (consistent with Nelson et al., 2013), 
suggesting that presence of H2-Db during development is necessary in preserving 
hippocampal cognition. MHC I molecules are detected in the prenatal and postnatal 
developing nervous system and play critical roles in the initial pruning and wiring of the 
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brain (Chacon and Boulanger, 2013; Glynn et al., 2011). Disruptions in the precise 
regulation of synapse elimination are a hallmark of many neurodevelopmental disorders 
such as autism spectrum disorders, Fragile X syndrome, and epilepsy (Chu et al., 2010; 
Comery et al., 1997; Hutsler and Zhang, 2010). Brain tissue from human patients or 
mouse models of these pathologies display increased synaptic density and impaired 
pruning, and interestingly, there is a high rate of co-diagnosis of these disorders with 
cognitive dysfunction (van Rijckevorsel, 2006; Zoghbi and Bear, 2012). My studies 
reveal that the presence of H2-Db is required for cognitive function, possibly in part due 
to its mediation of activity-dependent neural wiring in early brain development. Without 
guidance of post-natal synaptic pruning by MHC I, exceedingly dense hippocampal 
circuits may lead to lifelong impairments in learning and memory.  
 It is also plausible that increased LTP and nonexistent LTD may lead to a 
saturation in hippocampal circuits, occluding further plastic changes required to facilitate 
learning or the retrieval of memories. It has been shown that animals receiving high-
frequency stimulation in the perforant pathway of the hippocampus failed to learn a 
spatial water maze task if no further LTP could be induced in the pathway (Moser, 
1998). Indeed, there are several examples where mice with genetic mutations (deletion 
of post-synaptic density 95 or Fragile mental retardation 2) that cause enhancements in 
LTP show learning deficits in the water maze and fear conditioning tasks (Gu et al., 
2002; Migaud et al., 1998). It is conceivable that in D-/- mice, behavioral training can 
cause too many synapses within the network to become strongly potentiated. With LTD 
absent, not enough synapses become depressed which manifests as compromised 
information storage and recall capacity.  
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 Though I believe the cognitive phenotypes are likely a direct consequence of lack 
of H2-Db in the CNS, there is the possibility that they are an indirect result of a 
compromised immune system in the genetic knockout models. Initial characterizations 
found peripheral CD8+ T cells to be substantially reduced in K-/- mice (30-50%) and only 
slightly limited in D-/- mice (10-20%) (Perarnau et al., 1999). That fact that K-/- mice 
exhibit near-wild type levels of cognition despite a more altered peripheral immune 
profile lends support to the idea that CNS expression of MHC I accounts for the 
changes in cognition. Secondarily, Wolf et al. have also addressed the peripheral 
immune contribution to spatial learning; it was found that systemic depletion of CD4+ T 
cells impaired memory in the water maze, whereas systemic depletion of CD8+ T cells 
did not affect this ability (Wolf et al., 2009). K-/- and D-/- mice do not have impairments in 
CD4+ T cell numbers; rather, they are increased in compensation for the loss of CD8+ 
cells (Perarnau et al., 1999). Given these considerations, peripheral immunological 
deficits are unlikely to account for the impaired cognition seen in H2-Db-deficient mice. 
 To directly address hippocampal contribution of H2-Kb and H2-Db in cognition 
without effects of developmental compensation or systemic contribution in a constitutive 
knockout model, I made use of an in vivo RNAi strategy. Adult WT mice with a 
lentivirus-encoded shRNA targeting H2-Db injected bilaterally into the hippocampi 
surprisingly displayed cognitive phenotypes opposite of D-/- mice: acute knockdown of 
H2-Db in the DG improved learning and memory in the RAWM substantially over 
control-injected mice. These disparate results may result from the extent of H2-Db 
protein abrogation. The shRNA did not completely deplete H2-Db in the brain as is the 
case in a genetic mutant model; it is possible that the enhancement of LTP in this case 
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would not reach saturating levels, allowing for further LTP induction to improve 
performance during cognitive testing. Temporal control over the knockdown may also 
be critical. As these are WT mice with an acute injection, there would be no pruning or 
connectivity deficits from developmental periods that would affect cognitive testing later 
in life.  This demonstration that targeting one molecule for abrogation during adulthood 
can improve cognitive function has exciting potential for therapeutic implementation in 
CNS disorders with hippocampal dysfunction. But importantly, the electrophysiological 
and molecular mechanisms of how acute reduction of H2-Db alters hippocampal 
plasticity remain to be elucidated by future studies.  
 Finally, although major behavioral deficits were observed in D-/- mice, K-/- mice 
also displayed impairments though only in contextual fear conditioning. Mice lacking H2-
Kb have normal locomotor, anxiety, and spatial learning phenotypes despite absence of 
these molecules throughout development. This may be due to lower levels of CNS 
expression of H2-Kb or that its localization is not pertinent to the behaviors tested in 
these studies, or perhaps that H2-Kb individually is not necessary for driving proper 
synaptic pruning and neurite outgrowth during development. Another intriguing 
possibility is the ability of H2-Kb to regulate neural stem and progenitor cell (NSPC) 
function in the hippocampus, a manipulation that has the potential to impact 
hippocampus-dependent behaviors such as contextual fear conditioning (Saxe et al., 
2006). I have discovered that animals lacking H2-Kb show increased NSPC proliferation 
and neurogenesis in the adult hippocampus (see Chapter 3). Although the majority of 
studies show that ablation of hippocampal neurogenesis in adult animals impairs 
subsequent memory formation, a new line of evidence suggests that adult-born neurons 
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can additionally mediate forgetting by the retrograde disruption of memory circuits 
(Akers et al., 2014; Frankland et al., 2013). This hypothesis proposes that because 
immature neurons are more electrically excitable than mature ones (Ge et al., 2007), 
network homeostasis in the hippocampus may silence some previously existing circuits 
to compensate for the increased activity of dividing neuronal precursors, leading to 
degradation of information stored in them. Thus, the increase in hyperactive neuronal 
precursors observed in K-/- mice throughout adulthood could explain the impairment in 
contextual association memory.  
The disparities in cognitive and neurogenic phenotypes in K-/- and D-/- mice 
highlight for the first time distinct roles for each classical MHC I molecule in regulating 
separate CNS processes. Their expression and functions may, importantly, also differ 
between cell types of the brain. The generation of conditional knockout mice for specific 
MHC I proteins is our first step towards directly elucidating their roles in neurons, 
NSPCs, glial, and other cell types in a cell- autonomous manner.  
In summary, my results demonstrate the developmental necessity for a single 
MHC I molecule, H2-Db, in preserving normal locomotion, anxiety-related behavior, and 
spatial and contextual memory. Moreover, I show that its acute downregulation in the 
adult hippocampus can remarkably improve hippocampus-dependent memory.  
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Figure 1. Animals constitutively lacking H2-Db exhibit deficits in locomotion and 
anxiety. A four-point scale (A) was used to score 3-month-old mice lacking H2-Kb (K-/-), 
H2-Db (D-/-), or WT mice for nest formation 2 and 24 hours after single housing (B). 
Locomotor activity (C), as measured by total distance traveled, and time spent in center 
(D) were measured in WT, K-/-, and D-/- mice allowed to freely explore an open field for 
10 minutes. Overall activity level (E), measured by total distance travelled, as well as 
percent of time spent in open arms (F) during 10 minutes on the elevated zero maze 
were tested in WT, K-/-, and D-/- mice. WT n= 15, K-/- n= 10, D-/- n= 15. All data are 
represented as mean ± SEM; *p<0.05, **p<0.01, ****p<0.0001. One-way ANOVA with 
Dunnett’s post hoc test. 
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Figure 2. D-/- mice, but not K-/- mice, exhibit deficits in spatial learning and 
memory. 3-month-old WT, K-/-, and D-/- mice were tested for learning and memory in a 
two-day paradigm using a radial arm water maze with six arms (A). Day 1 consists of 12 
training trials where a visible and hidden escape platform is alternated, followed by 3 
hidden platform trials. Day 2 consists of 15 testing trials in which only a hidden platform 
is used (B). For each mouse, errors made in three consecutive trials were averaged (3 
trials = 1 block). K-/- mice exhibited no differences compared with WT mice in learning 
during training blocks or memory during testing blocks (C), whereas D-/- mice were 
impaired both in learning and memory of the task (D). WT n= 15, K-/- n= 10, D-/- n= 15. 
All data are represented as mean ± SEM; *p<0.05, ***p<0.0001; n.s., not significant. 
Two-way repeated measures ANOVA. 
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Figure 3. K-/- and D-/- mice have impaired associative memory in contextual, but 
not cued, fear conditioning. A two-day fear conditioning protocol was used to test 3-
month-old WT, K-/-, and D-/- mice in hippocampal-dependent (contextual) and 
independent (cued) forms of associative memory. On Day 1, each mouse was placed in 
a fear-conditioning chamber and allowed to explore for 2 min (baseline) before receiving 
two pairings of a tone and foot shock. On Day 2, each mouse was first placed in the 
same chamber (with no administration of a tone or foot shock) and percent time spent 
freezing during the first 30 seconds represents contextual memory. One hour later, mice 
were placed in a new context containing a different odor, floor, and walls. Animals were 
allowed to explore for 2 min before being re-exposed to the tone; percent time spent 
freezing during the subsequent 30 seconds represents cued memory (A). Baseline 
freezing (B), net contextual freezing (contextual minus baseline)(C), and net cued 
freezing (cued minus baseline)(D) were measured for WT, K-/-, and D-/- mice. WT n= 15, 
K-/- n= 10, D-/- n= 15. All data are represented as mean ± SEM; *p<0.05, **p<0.01. One-
way ANOVA with Dunnett’s post hoc test. 
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Figure 4. Design and validation of lentivirus-mediated shRNA strategy targeting 
H2-Kb and H2-Db in vivo. Schematic illustrating vector map of lentiviruses encoding H1 
promoter- driven short hairpin RNAs (shRNAs) targeting H2-Kb (sh-K), H2-Db (sh-D), or 
luciferase as a control (sh-control)(A). Bilateral stereotaxic injections into the dentate 
gyrus of the hippocampus were carried out in 2-month-old WT mice (B). Lentivirus-
encoded GFP (LV-GFP) could be visualized to confirm infection with the virus in the 
hippocampus six weeks after injection (C). A mouse neuro2a cell-line was used to 
confirm knockdown of H2-Kb and H2-Db via transfection with the respective lentiviral 
vectors. H2-Kb protein knockdown was confirmed by Western blot analysis (D-E) and 
H2-Db mRNA knockdown was confirmed by real-time PCR (F). In vitro experiments 
were carried out in triplicate, and all data are represented as mean ± SEM; 
****p<0.0001. Student’s t-test. 
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Figure 5. Acute knockdown of H2-Kb or H2-Db in the hippocampal dentate gyrus 
do not cause changes in locomotion or anxiety behaviors. Overall activity level (A), 
measured by total distance travelled, as well as percent of time spent in center (B) 
during 10 minutes in the open field were tested in 3-month-old WT mice bilaterally 
injected in the dentate gyrus with shRNA targeting H2-Kb (sh-K), H2-Db (sh-D) or 
luciferase (sh-control) as a control. n=14 per group and all data are represented as 
mean ± SEM. No significant differences, one-way ANOVA with Dunnett’s post hoc test. 
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Figure 6. Acute knockdown of H2-Db in the hippocampal dentate gyrus improves 
spatial memory. 3-month-old WT mice bilaterally injected with sh-K into the dentate 
gyrus exhibited no differences compared with sh-control-injected mice in learning during 
training blocks or memory during testing blocks (A). sh-D-injected mice exhibited 
improved spatial memory during the testing blocks (B). n= 14 per group, and all data are 
represented as mean ± SEM.  ****p<0.0001; n.s., not significant. Two-way repeated 
measures ANOVA. 
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Figure 7. Acute knockdown of H2-Kb or H2-Db in the hippocampal dentate gyrus 
do not cause changes in contextual or cued fear conditioning. No differences were 
detected in baseline freezing (A), net contextual freezing (B), or net cued freezing (C) in 
3-month-old WT mice bilaterally injected in the dentate gyrus with sh-K, sh-D, or sh-
control. n=14 per group and all data are represented as mean ± SEM. No significant 
differences, one-way ANOVA with Dunnett’s post hoc test. 
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Chapter 5 
Concluding Remarks and Future Directions 
 
 This chapter summarizes my findings on the newly uncovered roles of two 
specific MHC I molecules, H2-Kb and H2-Db, and the distinct function each plays in the 
central nervous system (CNS). In this dissertation, I show that H2-Kb molecules are 
involved in the regulation of neural stem and progenitor cell (NSPC) function and 
hippocampal neurogenesis, and identify the developmental necessity of H2-Db 
molecules in maintaining cognitive function throughout life. Additionally, I show that 
acute abrogation of H2-Kb and H2-Db can increase neurogenesis and improve learning 
and memory, respectively, in adult animals. Combined with the future investigations I 
will raise in this chapter, these results may have potential therapeutic applications in 
regenerative medicine and the treatment of neurological disorders that present with 
CNS dysfunction. In the following sections, I will present additional preliminary data that 
apply my findings towards combatting the neurogenic decline seen in aging, as well as 
address the broader implications of my research in other pathological conditions.  
 
 
Classical MHC I molecule, H2-Kb, is a negative regulator of NSPC proliferation and 
hippocampal neurogenesis 
Previous studies have described the inhibitory effects that MHC I molecules have 
on regulating neuronal processes such as neurite outgrowth, synaptogenesis, 
hippocampal and cerebellar synaptic plasticity, and activity-dependent refinement of 
developing visual system neurons (Glynn et al., 2011; Goddard et al., 2007; Huh et al., 
2000; McConnell et al., 2009b). My study provides the first evidence that one specific 
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MHC I molecule, H2-Kb, is critical in the regulation of non-neuronal cell types in the 
brain: NSPCs in the hippocampus. Using genetic mouse models as well as primary 
NSPC cultures, I show that deletion of H2-Kb (but not H2-Db) molecules causes 
increased proliferation and neurogenesis in the DG in vivo as well as increased cell 
division in NSPCs cultured in vitro. As primary NSPC cultures are devoid of any 
influence from other cell types of the niche or systemic environment, the inhibitory 
effects of endogenous H2-Kb molecules appear to be at the progenitor level. Another 
line of support comes from my analysis of a publically available dataset describing the 
transcriptomic dynamics of early phase adult hippocampal neurogenesis at the single-
cell level (Shin et al., 2015). In this early neurogenic trajectory where quiescent stem 
cells transition into activated progenitors, the H2-Kb expression trend line appears 
dynamic, decreasing as the cells become more proliferative; by contrast, H2-Db 
expression remains static. Using the same data set, I also found that NSCs and their 
immediate progeny are more likely to be non-cycling when enriched for H2-K1 (the gene 
encoding H2-Kb), reiterating the inhibitory influence of endogenous H2-Kb. 
I then recapitulated these results with an acute knockdown of H2-Kb specifically 
in the DG of the hippocampus where NSPCs reside. Lentivirus-mediated knockdown of 
H2-Kb enhanced hippocampal neurogenesis in the adult mouse in a spatially and 
temporally specific manner. However, to directly investigate the cell-autonomous effects 
of H2-Kb on NSPCs, the field would benefit from the generation of a conditional 
knockout model. Crossing these mice with NSPC-specific promoters will allow us to 
distinguish stem cell effects from contribution of nearby cells in vivo. 
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Although the exact contribution of adult hippocampal neurogenesis to cognitive 
function remains elusive, a number of studies have consistently shown the causal 
relationship between neurogenesis and hippocampus-dependent types of learning 
memory (reviewed in Costa et al., 2015 and Oomen et al., 2014). Future studies testing 
mice with H2-Kb conditionally deleted from NSPCs in cognitive tasks will help determine 
the functional implications of a knockout-induced increase in newborn neurons. As 
hippocampal neurogenesis in animal models is impaired in physiological aging as well 
as disease conditions associated with cognitive impairment, depression, and anxiety, 
elucidating novel targets that govern the neurogenic process carries intriguing 
therapeutic potential.   
 
H2-Kb regulates NSPC proliferation through modulation of growth factor receptor 
signaling  
 To gain mechanistic insight into how MHC I molecules regulate NSPC 
proliferation, I profiled gene expression in primary NSPCs derived from K-/- and WT 
mice using RNA-sequencing. Prior to this, there has been no unbiased transcriptomic 
analysis of any CNS cell type from MHC I-deficient mice. I performed pathway 
enrichment analysis for genes differentially regulated in K-/- NSPCs, and found an 
upregulation of several growth factor receptor-associated pathways, among these 
epidermal growth factor receptor (EGFR) and fibroblast growth factor receptor (FGFR) 
signaling. Interestingly, receptors (such as insulin receptors and EGFRs) and other 
proteins have been shown to associate in cis with MHC I molecules, forming 
macromolecular complexes on the same cell surface (Arosa et al., 2007; Dixon-Salazar 
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et al., 2014; Fehlmann et al., 1985; Schreiber et al., 1984). Given that these interactions 
can affect receptor signaling and internalization, I hypothesized that H2-Kb may be 
binding to receptors identified by our RNA sequencing experiment and potentially 
affecting their function. Coimmunoprecipitation experiments indeed showed that H2-Kb 
binds to specific FGFRs. Further experiments are required to establish how the 
formation of macromolecular complexes with H2-Kb affects the trafficking dynamics, 
internalization, and signaling capacity of growth factor receptors on NSPCs. More 
broadly, techniques such as protein mass spectrometry can be used to conduct an 
unbiased search for H2-Kb binding partners on neural or other stem cell types. Since all 
nucleated cells express MHC I molecules, these findings demonstrating their ability to 
modulate receptor signaling to affect proliferation may have biological implications for 
any healthy or pathological cell type with the ability to divide.  
 
Spatial and temporally-specific abrogation of classical MHC I molecule, H2-Db, 
can improve hippocampal-dependent cognitive function 
While H2-Db molecules appear to play little role in NSPCs, the second body of 
work in this dissertation illuminates their function in hippocampus-dependent behavior. 
Previous studies have discovered MHC I molecules to be unexpected regulators of 
synaptic plasticity in the hippocampus, as animals deficient for cell surface expression 
of these proteins display enhanced long-term potentiation (LTP) and absent long-term 
depression (LTD) (Fourgeaud et al., 2010; Huh et al., 2000). LTP and LTD are two 
mechanisms that underlie experience-dependent development, learning and memory, 
and their impairments are prominent in neurological disorders. Using H2-Kb  (K-/-) and 
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H2-Db (D-/-) genetic knockout mice, I found that the presence of H2-Db throughout 
development is required for mediating normal locomotor activity, anxiety-related 
behavior, and spatial and contextual memory. These findings reveal the specificity of 
one individual MHC I molecule H2-Db (of the more than 50 in the mouse genome) in 
regulating cognition, with the effects of the knockout potentially attributable to changes 
within and outside of the hippocampus. Intriguingly, though full-body, constitutive D-/- 
mice display marked behavioral abnormalities, the second main result of my studies 
demonstrates that acute knockdown of H2-Db localized by virally encoded shRNA 
injection to the hippocampus can elicit striking enhancements in spatial learning and 
memory in adult mice.  
The neurogenic phenotypes observed in K-/- mice and cognitive phenotypes 
observed in D-/- mice highlight for the first time distinct roles for each classical MHC I 
molecule in regulating separate CNS processes. One cause of these differences could 
be that their expression levels, binding or signaling partners, or even functions may 
differ between cell types of the brain. The generation of conditional knockout mice for 
specific MHC I proteins is our first step towards directly elucidating their roles in 
neurons, NSPCs, glial, and other cell types in a cell- autonomous manner. Future 
studies will make use of the conditional H2-Db knockout mouse we have generated to 
pinpoint whether the cognitive differences I observed were due only to neuronal H2-Db 
expression, or also contribution by other cell types. Forthcoming RNA sequencing of the 
hippocampi of D-/- mice as well as mice with an acute knockdown of H2-Db can 
complement my functional experiments by providing mechanistic insights into how this 
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molecule might regulate genes and pathways involved in hippocampal plasticity and 
associated cognitive function. 
 
MHC I as a potential therapeutic target in the aging CNS 
In the adult brain, NSCs in the dentate gyrus (DG) region of the hippocampus 
have the capacity for proliferation and differentiation into excitatory granule cells that 
integrate into hippocampal circuitry (Christian et al., 2014). Though ongoing, the 
process of neurogenesis exhibits significant age-related decline across species (Boldrini 
et al., 2018; Gould et al., 1999; Kuhn et al., 1996; Maslov et al., 2004; Sorrells et al., 
2018; Spalding et al., 2013), and stems from cell-intrinsic alterations, as well as 
changes to the neurogenic niche and systemic environment (Fan et al., 2017; Faigle 
and Song, 2013). While mechanisms underlying this age-related decline remain to be 
unraveled, identification of specific molecules regulating NSC function with age may 
allow us to develop means to maintain innate regenerative capacity well beyond 
developmental periods.  
My discovery that MHC I molecules negatively regulate hippocampal 
neurogenesis and cognitive function is particularly relevant because MHC I pathways 
and components, such as β2-microglobulin, have been shown to increase in the aging 
brain (Smith et al., 2015; Starkey et al., 2012). I built upon these findings by 
characterizing expression of classical MHCI molecules specifically, H2-Kb and H2-Db, in 
the hippocampus of adult and aged WT mice by quantitative real time PCR (qPCR) and 
Western blot analysis. I observed an increase in H2-Kb and H2-Db mRNA and H2-Kb 
protein in aged (18 months) compared to adult (3 months) mice (Figure 1A,B). As my 
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results described in Chapter 3 and Chapter 4 implicate MHC I molecules in adult 
neurogenesis and hippocampal-dependent cognitive processes, this observation posits 
these proteins as targets for abrogation in old age.  
To date, I have explored the potential benefit of decreasing surface expression of 
global MHC I molecules on age-related regenerative decline during normal physiological 
aging. Transporter associated with antigen processing 1 (Tap1) is critical for trafficking 
of MHCI molecules, with absence of Tap1 resulting in reduced stable expression of 
classical MHCI molecules at the cell surface (Kaer et al., 1992). I examined changes in 
adult hippocampal neurogenesis in young adult and aged Tap1 knockout (Tap1-/-) and 
WT control mice by immunohistochemical analysis. Cell proliferation was assessed by 
short-term BrdU-labeling of dividing cells. In young adult animals, reduced MHC I 
surface expression had no effect on the number of BrdU-positive proliferating cells or 
adult Dcx-positive neuroblasts in the DG (data not shown), consistent with previous 
reports (Laguna Goya et al., 2010; Smith et al., 2015). However, aged Tap1-/- mice had 
higher numbers of BrdU-positive and Dcx-positive cells compared to WT controls 
(Figure 1C,D). These preliminary data indicate that reduced expression of surface MHC 
I molecules has the potential to offset age-related regenerative decline. More specific 
studies abrogating H2-Kb specifically or localizing knockdown solely to NSCs in aged 
animals will be needed to directly explore this possibility.  
 
Broad implications of MHC I in disease 
Schizophrenia 
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 As we continue to unravel the immune contributions to CNS function, 
researchers are exploring neuroimmune-based mechanisms in the etiology, 
pathophysiology, and treatment of complex brain disorders. One such example is the 
increasing evidence pointing towards immune dysregulation in schizophrenia, a 
disabling disorder affecting 1% of the worldwide population and characterized by 
dissociation with reality and emotional and cognitive problems. Indeed, genetic 
aberrations on chromosome 6—which is densely comprised of immune genes— have 
been consistently linked with schizophrenia. More specifically, the MHC I has been 
independently identified as a region of association in three large-scale genome-wide 
association studies in schizophrenia (International Schizophrenia Consortium et al., 
2009; Shi et al., 2009; Stefansson et al., 2009). These types of studies showing that 
single nucleotide polymorphisms (SNPs) of schizophrenia tend to span the MHC region 
are correlational; hence, more research is needed to examine the functional outcomes 
of these SNPs, and specific manipulations of MHC I in models of schizophrenia would 
likewise be illuminating.  
 Reviewed in Chapter 1, there has been ample evidence for the direct role MHC I 
molecules play in the shaping and refinement of the developing CNS as well as synaptic 
plasticity in the adult hippocampus and cerebellum. Interestingly, the phenotypes 
observed in mice deficient of MHC I molecules are reminiscent of the neural 
deregulations of patients diagnosed with schizophrenia, suggesting their involvement in 
the etiology or pathophysiology of the disease. MHC I molecules inhibit synaptic density 
in the cortex throughout development; likewise in schizophrenia postmortem tissue, a 
decrease in synapse density and markers for dendritic spines are decreased (Stanley et 
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al., 1995). Another function MHC I has in the brain is the regulation of synaptic 
transmission and plasticity. MHC I molecules repress NMDA-type glutamate receptors, 
resulting in limited AMPA receptor trafficking and impaired activity-dependent changes 
in synaptic strength (Fourgeaud et al., 2010). NMDA receptor hypofunction is observed 
in schizophrenia and thought to cause impairments in synaptic plasticity (Gonzalez-
Burgos and Lewis, 2012; Snyder and Gao, 2013); could these deficits be cause, in part, 
by abnormal MHC I expression in neurons of susceptible individuals? 
 I show that, in addition to their involvement in CNS structure and connectivity, a 
specific MHC I molecule H2-Db can also influence hippocampal-dependent cognitive 
function. Although the structural and electrophysiology roles of MHC I developmentally 
may be more likely contributors to disease etiology, these findings relating to their role 
in cognition may be important in providing symptomatic relief, as impaired episodic 
memory has been directly associated to schizophrenia-related SNPs in MHC I (Walters 
et al., 2013). 
 The roles of MHC I in synaptic pruning, cognitive function, and even 
neurogenesis, could underlie some of the symptoms seen in neuropsychiatric disorders 
such as schizophrenia. It remains for future studies to use inducible, conditional 
transgenic mice to gain a more comprehensive understanding of the function of MHC I 
in various cell types and time points, and how this relates to the pathophysiology of 
disease.  
 
Cancer 
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Immunotherapy efforts, such as adoptive T-cell therapy, depend on MHC I-
mediated recognition of tumor-associated antigens to stimulate tumor rejection. 
However, downregulation of MHC I molecules is observed in 40-90% of all human 
tumors and a hallmark across a variety of adult and pediatric cancers (Haworth et al., 
2015). In many cases spanning neuroblastomas, Ewing scarcomas, colorectal, 
endometrial, and lung carcinomas, low MHC I expression predicts poor patient 
prognosis (Facoetti et al., 2005; Yeung et al., 2013). Classical cancer immunology 
attributes this unfavorable survival to the capability of tumors to evade both endogenous 
and therapeutic immune surveillance, as malignant cells can no longer be recognized 
by cytotoxic T lymphocytes (CTLs). However, novel evidence suggests that in addition 
to mediating cell-to-cell (or trans) interactions with T-cell receptors on immune cells, 
surface MHC I molecules also have the capability to interact in cis with other receptors 
on its own cell surface (Arosa et al., 2007). Specifically, MHC I molecules have been 
shown to form cis-associations with molecules such as EGFRs and insulin receptors 
(Dixon-Salazar et al., 2014; Schreiber et al., 1984), and has been proposed to inhibit 
signaling and modulate internalization. Thus, the loss of MHC I may exacerbate cancer 
progression by relieving cis-inhibitory-interactions with growth factor receptors on the 
surface of cancer cells, thereby promoting cell proliferation. 
Chapter 3 presents data supporting this hypothesis, using a cell type normally 
protected from peripheral immune influence. Transcriptomic profiling of primary 
hippocampal NSCs lacking the classical MHC I molecule H2-Kb revealed a significant 
increase in the expression of genes associated with several growth factor receptor-
associated pathways, such as PDGF, EGFR, and FGFR signaling. Of note, 
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overexpression or hyperactivity of these growth factor pathways have been clearly 
implicated in driving malignant growth (Heldin, 2013; Katoh and Nakagama, 2014; 
Normanno et al., 2006). Accordingly, K-/- NSCs exhibited increased proliferation when 
cultured in a cell-type specific environment in vitro. These data suggest that MHC I 
inhibits proliferation in a cell-intrinsic manner, possibly by inhibiting growth factor 
receptor signaling pathways, independent of its canonical immune function. The cell-
autonomous effects of MHC I loss on cancer cell proliferation remain to be studied and 
may be therapeutically co-opted as an additional means of tumor suppression. 
 
In summary, my studies have uncovered the distinct roles of two MHC I 
molecules which have until now been ascribed analogous functions in the brain. I have 
demonstrated that H2-Kb negatively regulates hippocampal NSC proliferation, likely 
through cis-inhibitory interactions with growth factor receptors. The discovery of a novel 
cellular regulator of a fundamental process such as proliferation may have relevance in 
both healthy and pathologically dividing cells, inside and outside of the brain. I also 
demonstrate the developmental necessity for H2-Db in preserving normal locomotion, 
anxiety-related behavior, and spatial and contextual memory. Excitingly, its acute 
downregulation in the adult DG can remarkably improve hippocampus-dependent 
memory. I hope that this work may provide foundations for future advances in the 
understanding of immune molecules and the non-canonical roles they play in shaping 
our brains, both in health and in disease.  
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Figure 1. Reduction in surface expression of global classical MHC I molecules 
offsets age-related neurogenic decline. Quantitative RT-PCR of H2-Db and H2-Kb 
mRNA from hippocampal lysates of adult (3 months) and aged (18 months) wild type 
(WT) mice (A). Representative Western blot and quantification of hippocampal lysates 
probed with anti-H2-Kb and anti-Actin antibodies from young and aged WT mice (B). 
Representative field of Dcx+ neuroblasts in the dentate gyrus (DG) of aged (18 months) 
WT and transporter associated with antigen processing 1 knockout (Tap1-/-) mice (C). 
Quantification BrdU+ proliferating cells and Dcx+ neuroblasts in the DG of aged WT and 
Tap1-/- mice (D). Scale bars, 50µm (C). WT n=5, Tap1-/- n=5 for histological analysis; 
n=3 replicates per group for RT-PCR and Western blot analysis. All data are 
represented as mean ± SEM; *p<0.05, **p<0.01. Student’s t-test (A,B,D). 
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